<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Cystic fibrosis transmembrane conductance regulator</title><meta name="description" content="More reference expression data Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene. Geneticist Lap-Chee Tsui and his team identified the CFTR gene in 1989 as the gene linked with CF (cystic fibrosis). The CFTR gene codes for an ABC transporter-class ion channel protein that conducts chloride and bicarbonate ions across epithelial cell membranes. Mutations of the CFTR gene affecting anion channel..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="CFTR"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Cystic_fibrosis_transmembrane_conductance_regulator"/><meta property="og:title" content="Cystic fibrosis transmembrane conductance regulator"/><meta property="og:description" content="More reference expression data Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene. Geneticist Lap-Chee Tsui and his team identified the CFTR gene in 1989 as the gene linked with CF (cystic fibrosis). The CFTR gene codes for an ABC transporter-class ion channel protein that conducts chloride and bicarbonate ions across epithelial cell membranes. Mutations of the CFTR gene affecting anion channel..."/><meta property="og:url" content="https://grokipedia.com/page/Cystic_fibrosis_transmembrane_conductance_regulator"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Cystic fibrosis transmembrane conductance regulator"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:14.060Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Cystic fibrosis transmembrane conductance regulator"/><meta name="twitter:description" content="More reference expression data Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene. Geneticist Lap-Chee Tsui and his team identified the CFTR gene in 1989 as the gene linked with CF (cystic fibrosis). The CFTR gene codes for an ABC transporter-class ion channel protein that conducts chloride and bicarbonate ions across epithelial cell membranes. Mutations of the CFTR gene affecting anion channel..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="915ae07408ee6d5cc2edceb6650d335e-0ff9594dfaa64c41-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=915ae07408ee6d5cc2edceb6650d335e,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.7657500970683255,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cystic-fibrosis-transmembrane-conductance-regulator" class="transition-opacity hover:opacity-100 opacity-50">Cystic fibrosis transmembrane conductance regulator</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#tissue-and-intracellular-localization" class="transition-opacity hover:opacity-100 opacity-50">Tissue and intracellular localization</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cftr-gene" class="transition-opacity hover:opacity-100 opacity-50">CFTR gene</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mutations" class="transition-opacity hover:opacity-100 opacity-50">Mutations</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#deltaf508" class="transition-opacity hover:opacity-100 opacity-50">DeltaF508</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#effects" class="transition-opacity hover:opacity-100 opacity-50">Effects</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mechanism" class="transition-opacity hover:opacity-100 opacity-50">Mechanism</a></li><li style="padding-left:2.25rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#prevalence" class="transition-opacity hover:opacity-100 opacity-50">Prevalence</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#structure" class="transition-opacity hover:opacity-100 opacity-50">Structure</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#location-and-function" class="transition-opacity hover:opacity-100 opacity-50">Location and function</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#clinical-implications" class="transition-opacity hover:opacity-100 opacity-50">Clinical implications</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#interactions" class="transition-opacity hover:opacity-100 opacity-50">Interactions</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#related-conditions" class="transition-opacity hover:opacity-100 opacity-50">Related conditions</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#drug-target" class="transition-opacity hover:opacity-100 opacity-50">Drug target</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="cystic-fibrosis-transmembrane-conductance-regulator" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Cystic fibrosis transmembrane conductance regulator<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>













<!-- -->













<!-- -->





















<!-- -->

























<!-- -->





























<!-- -->




















<!-- -->













<!-- -->













<!-- -->
<span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.bgee.org/gene/ENSG00000001626" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">More reference expression data</a><br/>
<a href="http://biogps.org/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">BioGPS</a> | n/a</span>

























<!-- -->



























































<!-- -->
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Cystic fibrosis transmembrane conductance regulator</strong> (<strong>CFTR</strong>) is a <span class="inline text-[1em] leading-7">membrane protein</span> and <span class="inline text-[1em] leading-7">anion channel</span> in vertebrates that is encoded by the <em>CFTR</em> <span class="inline text-[1em] leading-7">gene</span>.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Geneticist Lap-Chee Tsui and his team identified the <em>CFTR</em> gene in 1989 as the gene linked with CF (<span class="inline text-[1em] leading-7">cystic fibrosis</span>).</span>
<span class="mb-4 block break-words text-[1em] leading-7">The <em>CFTR</em> gene codes for an <span class="inline text-[1em] leading-7">ABC transporter</span>-class <span class="inline text-[1em] leading-7">ion channel</span> protein that conducts <span class="inline text-[1em] leading-7">chloride</span> and <span class="inline text-[1em] leading-7">bicarbonate</span> ions across <span class="inline text-[1em] leading-7">epithelial</span> <span class="inline text-[1em] leading-7">cell membranes</span>. Mutations of the <em>CFTR</em> gene affecting anion channel function lead to dysregulation of <span class="inline text-[1em] leading-7">epithelial lining fluid</span> (mucus) transport in the lung, pancreas and other organs, resulting in <span class="inline text-[1em] leading-7">cystic fibrosis</span>. Complications include thickened <span class="inline text-[1em] leading-7">mucus</span> in the lungs with frequent <span class="inline text-[1em] leading-7">respiratory infections</span>, and <span class="inline text-[1em] leading-7">pancreatic insufficiency</span> giving rise to malnutrition and <span class="inline text-[1em] leading-7">diabetes</span>. These conditions lead to chronic disability and reduced life expectancy. In male patients, the progressive obstruction and destruction of the developing <span class="inline text-[1em] leading-7">vas deferens</span> (spermatic cord) and <span class="inline text-[1em] leading-7">epididymis</span> appear to result from abnormal intraluminal secretions, causing <span class="inline text-[1em] leading-7">congenital absence of the vas deferens</span> and male infertility, and found associated with an imbalance of <span class="inline text-[1em] leading-7">fatty acids</span>.</span>
<h2 id="tissue-and-intracellular-localization" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Tissue and intracellular localization<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The CFTR is found in the epithelial cells of many organs including the lung, liver, pancreas, digestive tract, and the female reproductive tract<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> and male reproductive tract including the testis, Sertoli cells, spermatozoa.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> epididymis,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_68abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> and the vas deferens.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the airways of the lung, CFTR is most highly expressed by rare specialized cells called pulmonary ionocytes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_38qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> In the skin, CFTR is strongly expressed in the sebaceous and eccrine sweat glands.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_68qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> In the eccrine glands, CFTR is located on the apical membrane of the epithelial cells that make up the duct of these sweat glands.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Normally, the protein allows movement of chloride, bicarbonate and thiocyanate<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> ions (with a negative charge) out of an epithelial cell into the airway surface liquid and mucus. Positively charged sodium ions follow passively, increasing the total electrolyte concentration in the mucus, resulting in the movement of water out of the cell via osmosis.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In epithelial cells with motile cilia lining the bronchus and the oviduct, CFTR is located on the apical cell membrane but not on cilia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> In contrast, ENaC (Epithelial sodium channel) is located along the entire length of the cilia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In sweat glands, defective CFTR results in reduced transport of sodium chloride and sodium thiocyanate<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> in the resorptive duct and therefore saltier sweat. This is the basis of a clinically important sweat test for cystic fibrosis often used diagnostically with genetic screening.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup></span>
<h1 id="cftr-gene" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">CFTR gene<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">The gene that encodes the human CFTR protein is found on <span class="inline text-[1em] leading-7">chromosome 7</span>, on the long arm at position q31.2, from base pair 117,287,120 to base pair 117,715,971 (GRCh38.p14). <em>CFTR</em> <span class="inline text-[1em] leading-7">orthologs</span> occur in vertebrates, including both jawed and jawless species.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Each individual inherits two copies of the <em>CFTR</em> (cystic fibrosis transmembrane conductance regulator) gene. However, some of the inherited copies have been altered. As of 2024, the <em>CFTR</em> gene has been associated with over 2,000 distinct mutations, with approximately 400 classified as CF-causing. An individual with CF inherits two defective copies of the <em>CFTR</em> gene. These mutations might be heterozygous, meaning they include two different mutations, and homozygous, meaning they involve the same mutation. Delta F508 is the most common mutation, accounting for approximately 70% of CF-causing alleles in individuals with cystic fibrosis, particularly in populations of European descent. Those who are homozygous for Delta F508 are commonly affected by pancreatic insufficiency.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The <em>CFTR</em> gene has been used in animals as a <span class="inline text-[1em] leading-7">nuclear DNA</span> phylogenetic marker. Large genomic sequences of this gene have been used to explore the <span class="inline text-[1em] leading-7">phylogeny</span> of the major groups of <span class="inline text-[1em] leading-7">mammals</span>, and confirmed the grouping of <span class="inline text-[1em] leading-7">placental</span> orders into four major clades: <span class="inline text-[1em] leading-7">Xenarthra</span>, <span class="inline text-[1em] leading-7">Afrotheria</span>, <span class="inline text-[1em] leading-7">Laurasiatheria</span>, and <span class="inline text-[1em] leading-7">Euarchonta</span> plus <span class="inline text-[1em] leading-7">Glires</span>.</span>
<h3 id="mutations" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Mutations<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Nearly 2,000 cystic fibrosis-associated mutations have been described, with over 400 classified as CF-causing as of 2024. The most common mutation, DeltaF508 (Î”F508) primarily known as a processing mutation which results from a deletion (Î”) of three nucleotides which results in a loss of the amino acid <span class="inline text-[1em] leading-7">phenylalanine</span> (F) at the 508th position on the protein. As a result, the protein does not <span class="inline text-[1em] leading-7">fold</span> normally and is more quickly degraded. The vast majority of mutations are infrequent. The distribution and frequency of mutations varies among different populations which has implications for genetic screening and counseling. DeltaF508 frequency varies globally, reaching ~70% of CF alleles in European-descent populations but lower in Asian and African groups.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Drug discovery for therapeutics to address CF in all patients is complicated due to a large number of disease-causing mutations. Ideally, a library of cell lines and cell-based assays corresponding to all mutants is required to screen for broadly-active drug candidates. Cell engineering methods including fluorogenic oligonucleotide signaling probes may be used to detect and isolate clonal cell lines for each mutant.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Mutations consist of replacements, duplications, deletions or shortenings in the <em>CFTR</em> gene. This may result in proteins that may not function, work less effectively, are more quickly degraded, or are present in inadequate numbers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">It has been hypothesized that mutations in the <em>CFTR</em> gene may confer a selective advantage to heterozygous individuals. Cells expressing a mutant form of the CFTR protein are resistant to invasion by the <em>Salmonella typhi</em> bacterium, the agent of <span class="inline text-[1em] leading-7">typhoid fever</span>, and mice carrying a single copy of mutant <em>CFTR</em> are resistant to diarrhea caused by cholera toxin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aeqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The most common mutations that cause cystic fibrosis and pancreatic insufficiency in humans are:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>

























































































































































































































































































































































































































































































































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Variant cDNA name (ordered 5&#x27; to 3&#x27;)</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Variant protein name</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Variant legacy name</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">rsID</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7"># alleles in CFTR2</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Allele frequency in CFTR2</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">% pancreatic insufficient</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Variant final determination (as of September 2024)</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1521_1523delCTT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Phe508del</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">F508del</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs113993960</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99061</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.69744</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1624G&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Gly542X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">G542X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs113993959</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3610</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.02542</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1652G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Gly551Asp</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">G551D</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs75527207</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2986</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.02102</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">96%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3909C&gt;G</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Asn1303Lys</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">N1303K</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs80034486</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2246</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.01581</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.350G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg117His</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R117H</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs78655421</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1854</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.01305</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">23%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Varying clinical consequence</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3846G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Trp1282X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">W1282X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77010898</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1726</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.01215</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.489+1G&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">621+1G-&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs78756941</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1323</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00931</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1657C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg553X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R553X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs74597325</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1323</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00931</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">97%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1585-1G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1717-1G-&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs76713772</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1216</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00856</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">97%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3718-2477C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3849+10kbC-&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs75039782</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1158</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00815</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">33%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.2657+5G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2789+5G-&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs80224560</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1027</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00723</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">43%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1519_1521delATC</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Ile507del</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">I507del</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908745</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">651</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00458</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3484C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg1162X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R1162X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs74767530</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">651</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00458</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">97%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.254G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Gly85Glu</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">G85E</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs75961395</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">616</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00434</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">85%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3454G&gt;C</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Asp1152His</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">D1152H</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs75541969</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">571</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00402</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">24%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Varying clinical consequence</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.2051_2052delAAinsG</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Lys684SerfsX38</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2183AA-&gt;G</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908799</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">542</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00382</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">96%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3528delC</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Lys1177SerfsX15</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3659delC</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908747</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">539</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00379</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1040G&gt;C</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg347Pro</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R347P</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77932196</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">533</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00375</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">68%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1210âˆ’12T</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aefqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs1805177</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">516</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00363</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">28%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Varying clinical consequence</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.2988+1G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3120+1G-&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs75096551</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">501</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00353</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1364C&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Ala455Glu</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">A455E</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs74551128</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">500</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00352</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">34%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3140-26A&gt;G</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3272-26A-&gt;G</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs76151804</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">470</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00331</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">29%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1000C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg334Trp</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R334W</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121909011</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">429</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00302</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">40%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1766+1G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1898+1G-&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908748</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">421</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00296</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.54-5940_273+10250del21kb</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Ser18ArgfsX16</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CFTRdele2,3</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">not found</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">417</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00294</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">100%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1679G&gt;C</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg560Thr</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R560T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs80055610</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">343</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00241</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.617T&gt;G</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Leu206Trp</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">L206W</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908752</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">333</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00234</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">20%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.2052dupA</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Gln685ThrfsX4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2184insA</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908786</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">329</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00232</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">85%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.262_263delTT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Leu88IlefsX22</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">394delTT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908769</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">307</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00216</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">97%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.178G&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Glu60X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">E60X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77284892</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">296</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00208</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1477C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Gln493X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Q493X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77101217</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">292</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00206</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.579+1G&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">711+1G-&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77188391</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">274</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00193</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.2052delA</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Lys684AsnfsX38</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">2184delA</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908746</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">255</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00180</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.200C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Pro67Leu</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">P67L</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs368505753</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">239</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00168</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">34%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3302T&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Met1101Lys</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">M1101K</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs36210737</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">238</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00168</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">69%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1408A&gt;G</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Met470Val</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">M470V</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs213950</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">235</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00165</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">46%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Non CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3276C&gt;A or c.3276C&gt;G</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Tyr1092X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Y1092X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908761</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">225</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00158</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3196C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg1066Cys</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R1066C</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs78194216</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">220</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00155</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1021_1022dupTC</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Phe342HisfsX28</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1154insTC</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs387906360</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">214</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00151</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3773dupT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Leu1258PhefsX7</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">3905insT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908789</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">210</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00148</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">97%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1646G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Ser549Asn</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">S549N</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908755</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">203</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00143</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">84%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1040G&gt;A</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg347His</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R347H</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77932196</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">199</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00140</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">24%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.948delT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Phe316LeufsX12</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">1078delT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs121908744</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">184</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00130</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1210-33_1210-6GT</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8difqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><span class="text-[1em] leading-7">T</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gdifqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">No protein name</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">5T;TG12</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">not found</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">182</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00128</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">14%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Varying clinical consequence</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.3472C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg1158X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R1158X</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs79850223</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">179</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00126</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">99%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.2834C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Ser945Leu</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">S945L</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs397508442</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">167</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00118</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">40%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.1558G&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Val520Phe</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">V520F</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77646904</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">156</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00110</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">98%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.443T&gt;C</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p. Ile148Thr</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">I148T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs35516286</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">148</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00104</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">88%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Non CF-causing</span></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">c.349C&gt;T</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">p.Arg117Cys</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">R117C</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">rs77834169</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">146</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">0.00103</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">24%</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">CF-causing</span></td></tr></tbody></table></div>
<h3 id="deltaf508" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">DeltaF508<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>DeltaF508</strong> (<strong>Î”F508</strong>), full name <strong>CFTRÎ”F508</strong> or <strong>F508del-CFTR</strong> (<a href="https://www.ncbi.nlm.nih.gov/snp/rs113993960" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">rs113993960</a>), is a specific mutation within the CFTR gene involving <span class="inline text-[1em] leading-7">deletion</span> of three <span class="inline text-[1em] leading-7">nucleotides</span> spanning codons for amino acid positions 507 and 508 of the CFTR gene on chromosome 7, which ultimately results in the loss of a single <span class="inline text-[1em] leading-7">codon</span> for the <span class="inline text-[1em] leading-7">amino acid</span> <span class="inline text-[1em] leading-7">phenylalanine</span> (F). A person with the CFTRÎ”F508 mutation will produce an abnormal CFTR protein that lacks this phenylalanine residue and which cannot <span class="inline text-[1em] leading-7">fold</span> properly. Most of this mutated protein does not escape the <span class="inline text-[1em] leading-7">endoplasmic reticulum</span> for further processing. The small amounts that reach the plasma membrane are destabilized and the anion channel opens infrequently. Having two copies of this mutation (one inherited from each parent) is by far the most common cause of <span class="inline text-[1em] leading-7">cystic fibrosis</span> (CF), responsible for approximately 70% of CF alleles in patients of European descent, though the frequency is lower worldwide.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_rgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_sgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<h4 id="effects" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">The CFTR protein is largely expressed in cells of the pancreas, intestinal and respiratory epithelia, and all exocrine glands. When properly folded, it is shuttled to the cell membrane, where it becomes a transmembrane protein that forms aqueous channels allowing the flow of <span class="inline text-[1em] leading-7">chloride</span> and <span class="inline text-[1em] leading-7">bicarbonate</span> ions out of cells; it also simultaneously inhibits the uptake of <span class="inline text-[1em] leading-7">sodium</span> ions by another channel protein. Both of these functions help to maintain an <span class="inline text-[1em] leading-7">ion gradient</span> that causes <span class="inline text-[1em] leading-7">osmosis</span> to draw water out of the cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_chqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> The Î”F508 mutation leads to the misfolding of CFTR and its eventual <span class="inline text-[1em] leading-7">degradation in the ER</span>. In organisms with two complements of the mutation, the protein is almost entirely absent from the cell membrane, and these critical ion transport functions are not performed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ghqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Having a <span class="inline text-[1em] leading-7">homozygous</span> pair of genes with the Î”F508 mutation prevents the CFTR protein from assuming its normal position in the cell membrane. This causes increased water retention in cells, corresponding dehydration of the extracellular space, and an associated cascade of effects on various parts of the body. These effects include: thicker <span class="inline text-[1em] leading-7">mucous membranes</span> in the epithelia of afflicted organs; obstruction of narrow respiratory airways as a result of thicker mucus and inhibition of the free movement of muco cilia; <span class="inline text-[1em] leading-7">congenital absence of the vas deferens</span> due to increased mucus thickness during fetal development; pancreatic insufficiency due to blockage of the pancreatic duct with mucus; and increased risk of respiratory infection due to build-up of thick, nutrient-rich mucus where bacteria thrive. These are the symptoms of <span class="inline text-[1em] leading-7">cystic fibrosis</span>, a genetic disorder; however, Î”F508 is not the only mutation that causes this disorder.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Being a <span class="inline text-[1em] leading-7">heterozygous</span> <span class="inline text-[1em] leading-7">carrier</span> (having a single copy of Î”F508) results in decreased water loss during <span class="inline text-[1em] leading-7">diarrhea</span> because malfunctioning or absent CFTR proteins cannot maintain stable ion gradients across cell membranes. Typical nucleotide-binding-up of both Clâ» and Naâº ions inside affected cells, creating a <span class="inline text-[1em] leading-7">hypotonic</span> solution outside the cells and causing water to diffuse into the cells by osmosis. Several studies indicate that heterozygous carriers are at increased risk for various symptoms. For example, it has been shown that heterozygosity for cystic fibrosis is associated with increased airway reactivity, and heterozygotes may be at risk for poor pulmonary function. Heterozygotes with wheeze have been shown to be at higher risk for poor pulmonary function or development and progression of chronic <span class="inline text-[1em] leading-7">obstructive lung disease</span>. One gene for cystic fibrosis is sufficient to produce mild lung abnormalities even in the absence of infection.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ciqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<h4 id="mechanism" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Mechanism<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">The <em>CFTR</em> gene is located on the long arm of chromosome 7, at position q31.2, and ultimately codes for a sequence of 1,480 amino acids. Normally, the three <span class="inline text-[1em] leading-7">DNA</span> <span class="inline text-[1em] leading-7">base pairs</span> A-T-C (paired with T-A-G on the opposite strand) at the gene&#x27;s 507th position form the template for the mRNA codon A-U-C for <span class="inline text-[1em] leading-7">isoleucine</span>, while the three DNA base pairs T-T-T (paired with A-A-A) at the adjacent 508th position form the template for the codon U-U-U for <span class="inline text-[1em] leading-7">phenylalanine</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> The Î”F508 mutation is a deletion of the C-G pair from position 507 along with the first two T-A pairs from position 508, leaving the DNA sequence A-T-T (paired with T-A-A) at position 507, which is <span class="inline text-[1em] leading-7">transcribed</span> into the mRNA codon A-U-U. Since A-U-U also codes for isoleucine, position 507&#x27;s amino acid does not change, and the mutation&#x27;s net effect is equivalent to a deletion (&quot;Î”&quot;) of the sequence resulting in the codon for phenylalanine at position 508.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gjqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup></span>
<h4 id="prevalence" class="group relative mb-1.5 mt-7 scroll-mt-24 font-serif text-[1.142857em] font-semibold" node="[object Object]">Prevalence<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h4>
<span class="mb-4 block break-words text-[1em] leading-7">Î”F508 is present on at least one copy of chromosome 7 in approximately one in 30 <span class="inline text-[1em] leading-7">Caucasians</span>. Presence of the mutation on both copies causes the <span class="inline text-[1em] leading-7">autosomal recessive</span> disease cystic fibrosis. Scientists have estimated that the original mutation occurred over 52,000 years ago in Northern <span class="inline text-[1em] leading-7">Europe</span> though <span class="inline text-[1em] leading-7">cystic fibrosis patients of other ethnicities</span> are also known to harbor the mutation. The young <span class="inline text-[1em] leading-7">allele age</span> may be a consequence of past selection. One hypothesis as to why the otherwise detrimental mutation has been maintained by natural selection is that a single copy may present a positive effect by reducing water loss during <span class="inline text-[1em] leading-7">cholera</span>, though the introduction of pathogenic <em><span class="inline text-[1em] leading-7">Vibrio cholerae</span></em> into Europe did not occur until the late 18th century.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> Another theory posits that CF carriers (heterozygotes for Î”F508) are more resistant to <span class="inline text-[1em] leading-7">typhoid fever</span>, since CFTR has been shown to act as a receptor for <em><span class="inline text-[1em] leading-7">Salmonella typhi</span></em> bacteria to enter intestinal epithelial cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cystic fibrosis Î”F508 heterozygotes may be overrepresented among individuals with <span class="inline text-[1em] leading-7">asthma</span> and may have poorer lung function than non-carriers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> Carriers of a single CF mutation have a higher prevalence of chronic <span class="inline text-[1em] leading-7">rhinosinusitis</span> than the general population.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup> Approximately 50% of cystic fibrosis cases in <span class="inline text-[1em] leading-7">Europe</span> are due to homozygous Î”F508 mutations (this varies widely by region), while the allele frequency of Î”F508 is about 70%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dlabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup> The remaining cases are caused by over 1,500 other mutations, including R117H, 1717-1G&gt;A, and 2789+56G&gt;A. These mutations, when combined with each other or even a single copy of Î”F508, may cause CF symptoms. The genotype is not strongly correlated with severity of the CF, though specific symptoms have been linked to certain mutations.</span>
<h2 id="structure" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Structure<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The <em>CFTR</em> gene is approximately 189 <span class="inline text-[1em] leading-7">kb</span> in length, with 27 <span class="inline text-[1em] leading-7">exons</span> and 26 <span class="inline text-[1em] leading-7">introns</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_amabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> CFTR is a glycoprotein and is found on the surface of many epithelial cells in the body.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> CFTR consists of five domains, which include two transmembrane or membrane-spanning domains, two nucleotide-binding domains and a regulatory domain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_emabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup> The transmembrane domains are each connected to a <span class="inline text-[1em] leading-7">nucleotide binding domain</span> (NBD) in the cytoplasm. The first NBD is connected to the second transmembrane domain by a regulatory &quot;R&quot; domain that is a unique feature of CFTR, not present in other <span class="inline text-[1em] leading-7">ABC transporters</span> which carries 19 predicted sites for protein kinase A(PKA). Six of these have been reported to be phosphorylated in vivo.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> The ion channel only opens when its R-domain has been phosphorylated by PKA and <span class="inline text-[1em] leading-7">ATP</span> is bound at the NBDs. Phosphorylation displaces the disordered R domain from positions preventing NBD dimerization and opening.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_omabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_pmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup> The <span class="inline text-[1em] leading-7">amino-terminus</span> is part of the lasso motif which anchors into the cell membrane.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_tmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> The <span class="inline text-[1em] leading-7">carboxyl terminal</span> of the protein is anchored to the <span class="inline text-[1em] leading-7">cytoskeleton</span> by a <span class="inline text-[1em] leading-7">PDZ</span>-interacting domain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_15mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup></span>
<h2 id="location-and-function" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Location and function<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">The CFTR protein is an anion channel that conducts chloride (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mstyle mathcolor="#cc0000"><mtext>\Cl</mtext></mstyle><mo>âˆ’</mo></msup></mrow><annotation encoding="application/x-tex">\Cl^-</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1612em;vertical-align:-0.25em"></span><span class="mord"><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\Cl</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.9112em"><span style="top:-3.2029em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ’</span></span></span></span></span></span></span></span></span></span></span>) and bicarbonate (<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mstyle mathcolor="#cc0000"><mtext>\ce</mtext></mstyle><mrow><mi>H</mi><mi>C</mi><mi>O</mi><msup><mn>3</mn><mo>âˆ’</mo></msup></mrow></mrow><annotation encoding="application/x-tex">\ce{HCO3^-}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.0213em;vertical-align:-0.25em"></span><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\ce</span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.08125em">H</span><span class="mord mathnormal" style="margin-right:0.02778em">CO</span><span class="mord"><span class="mord">3</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.7713em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ’</span></span></span></span></span></span></span></span></span></span></span></span>) ions across the apical membranes of epithelial cells in various organs, including the lungs, pancreas, and intestines. This ion transport helps regulate the osmotic movement of water. When functioning correctly, as shown in Panel 1, anions flow through open CFTR channels. However, in cystic fibrosis, defective CFTR function impairs anion secretion, leading to osmotic imbalances and thick mucus buildup in affected organs, as illustrated in Panel 2.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The <em>CFTR</em> gene consists of 27 exons and is located on the long (q) arm of chromosome 7 at position 7q31.2. Exons are the coding segments of the gene that specify the amino acid sequence of the protein.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup> CFTR functions as a phosphorylation- and ATP-gated anion channel that increases conductance for anions such as <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mstyle mathcolor="#cc0000"><mtext>\Cl</mtext></mstyle><mo>âˆ’</mo></msup></mrow><annotation encoding="application/x-tex">\Cl^-</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1612em;vertical-align:-0.25em"></span><span class="mord"><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\Cl</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.9112em"><span style="top:-3.2029em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ’</span></span></span></span></span></span></span></span></span></span></span> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mstyle mathcolor="#cc0000"><mtext>\ce</mtext></mstyle><mrow><mi>H</mi><mi>C</mi><mi>O</mi><msup><mn>3</mn><mo>âˆ’</mo></msup></mrow></mrow><annotation encoding="application/x-tex">\ce{HCO3^-}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.0213em;vertical-align:-0.25em"></span><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\ce</span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.08125em">H</span><span class="mord mathnormal" style="margin-right:0.02778em">CO</span><span class="mord"><span class="mord">3</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.7713em"><span style="top:-3.063em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ’</span></span></span></span></span></span></span></span></span></span></span></span>, allowing them to flow down their electrochemical gradient. ATP-driven conformational changes in CFTR open and close a gate to permit transmembrane anion flow.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_anqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> This contrasts with other ABC proteins, in which ATP-driven conformational changes drive active transport of substrates against their electrochemical gradient. Essentially, CFTR is an ion channel that evolved from an ABC transporter, functioning as a &quot;broken&quot; transporter that permits passive anion leakage in its open conformation.</span>
<span class="mb-4 block break-words text-[1em] leading-7">CFTR consists of five domains: two transmembrane domains (TMD1 and TMD2), two nucleotide-binding domains (NBD1 and NBD2), and a regulatory (R) domain. Other members of the ABC transporter superfamily facilitate nutrient uptake in prokaryotes or export of substrates in eukaryotes. ABC transporters transduce ATP hydrolysis energy to move substrates uphill across membranes. They alternate between inward-facing (ATP-free) and outward-facing (ATP-bound) conformations. ATP binding to the NBDs promotes dimerization, rearranging transmembrane helices and exposing the substrate site outwardly. Subsequent ATP hydrolysis drives the cycle, ensuring unidirectional transport. In CFTR, transitions between inward- and outward-facing conformations control channel gating. Specifically, ATP binding favors NBD dimerization and an outward-facing open pathway for anions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> Hydrolysis at the canonical site 2 (in NBD2, involving Walker motifs) destabilizes the dimer, returning to the inward-facing closed state.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<h2 id="clinical-implications" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Clinical implications<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Mutations in the <em>CFTR</em> gene are classified into six classes (Iâ€“VI) based on their effect on protein production, trafficking, or function, leading to varying degrees of cystic fibrosis (CF) severity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Common manifestations include chronic lung infections, pancreatic insufficiency, and elevated sweat chloride levels (&gt;60 mmol/L, a key diagnostic marker).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Mutation-specific therapies, known as CFTR modulators (e.g., ivacaftor for Class III/IV, elexacaftor/tezacaftor/ivacaftor [Trikafta] for Class II like F508del, and vanzacaftor/tezacaftor/deutivacaftor [Alyftrek, approved 2024]), correct underlying defects and improve lung function and quality of life, with median life expectancy now exceeding 50 years as of 2025.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup></span>
<h3 id="interactions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Interactions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The cystic fibrosis transmembrane conductance regulator has been shown to interact with:</span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">DNAJC5,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_22qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></li>
<li class="text-[1em]">GOPC,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_24qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_34qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></li>
<li class="text-[1em]">PDZK1,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_26qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_36qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup></li>
<li class="text-[1em]">PRKCE,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup></li>
<li class="text-[1em]">SLC4A7,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup></li>
<li class="text-[1em]">SNAP23,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2cqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup></li>
<li class="text-[1em]">SLC9A3R1,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2eqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3eqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5eqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6eqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7eqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup></li>
<li class="text-[1em]">SLC9A3R2,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2gqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> and</li>
<li class="text-[1em]">STX1A.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3iqqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup></li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">It is inhibited by the antidiarrheal drug crofelemer.[Tradtrantip et al. 2009]</span>
<h2 id="related-conditions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Related conditions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Congenital bilateral absence of the vas deferens</span>: Males with congenital bilateral absence of the <span class="inline text-[1em] leading-7">vas deferens</span> most often have a mild <span class="inline text-[1em] leading-7">mutation</span> (a change that allows partial function of the gene) in one copy of the CFTR gene and a cystic fibrosis-causing mutation in the other copy of CFTR.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f2sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup></span>
</li>
<li class="text-[1em]">
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Cystic fibrosis</span>: Caused by biallelic pathogenic variants in the CFTR gene (see [[Gene#Mutations]] for details on over 2,000 identified variants, of which ~700 are CF-causing).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_74sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_94sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup></span>
</li>
<li class="text-[1em]">
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Cholera</span>: <span class="inline text-[1em] leading-7">ADP-ribosylation</span> caused by <span class="inline text-[1em] leading-7">cholera toxin</span> results in increased production of <span class="inline text-[1em] leading-7">cyclic AMP</span>, which in turn opens the CFTR channel, leading to oversecretion of <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mstyle mathcolor="#cc0000"><mtext>\Cl</mtext></mstyle><mo>âˆ’</mo></msup></mrow><annotation encoding="application/x-tex">\Cl^-</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1612em;vertical-align:-0.25em"></span><span class="mord"><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\Cl</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.9112em"><span style="top:-3.2029em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ’</span></span></span></span></span></span></span></span></span></span></span>. <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mstyle mathcolor="#cc0000"><mtext>\Na</mtext></mstyle><mo>+</mo></msup></mrow><annotation encoding="application/x-tex">\Na^+</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1612em;vertical-align:-0.25em"></span><span class="mord"><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\Na</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.9112em"><span style="top:-3.2029em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">+</span></span></span></span></span></span></span></span></span></span></span> and <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mstyle mathcolor="#cc0000"><mtext>\ce</mtext></mstyle><mrow><mi>H</mi><mn>2</mn><mi>O</mi></mrow></mrow><annotation encoding="application/x-tex">\ce{H2O}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1em;vertical-align:-0.25em"></span><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\ce</span></span><span class="mord"><span class="mord mathnormal" style="margin-right:0.08125em">H</span><span class="mord">2</span><span class="mord mathnormal" style="margin-right:0.02778em">O</span></span></span></span></span> follow <span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mstyle mathcolor="#cc0000"><mtext>\Cl</mtext></mstyle><mo>âˆ’</mo></msup></mrow><annotation encoding="application/x-tex">\Cl^-</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.1612em;vertical-align:-0.25em"></span><span class="mord"><span class="mord text" style="color:#cc0000"><span class="mord" style="color:#cc0000">\Cl</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height:0.9112em"><span style="top:-3.2029em;margin-right:0.05em"><span class="pstrut" style="height:2.7em"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">âˆ’</span></span></span></span></span></span></span></span></span></span></span> into the small intestine, resulting in dehydration and loss of electrolytes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_136sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup></span>
</li>
<li class="text-[1em]">
<span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">CFTR-related disorders</span>: Conditions associated with CFTR dysfunction that do not meet full diagnostic criteria for cystic fibrosis, including idiopathic chronic pancreatitis, disseminated bronchiectasis, and male infertility due to CFTR variants. Heterozygous carriers may have increased risk for chronic rhinosinusitis and asthma.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_78sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup></span>
</li>
</ul>
<h1 id="drug-target" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Drug target<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">CFTR has been a drug target in efforts to find treatments for cystic fibrosis. <span class="inline text-[1em] leading-7">Ivacaftor</span> (brand name Kalydeco, developed as VX-770) is a medication approved by the FDA on January 31, 2012, for people with cystic fibrosis who have specific CFTR mutations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup> Ivacaftor was developed by <span class="inline text-[1em] leading-7">Vertex Pharmaceuticals</span> in conjunction with the <span class="inline text-[1em] leading-7">Cystic Fibrosis Foundation</span> and is the first medication that treats the underlying cause rather than the symptoms of the disease.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_atabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_btabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup> It has been described as &quot;a wonder drug.&quot;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dtabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Other approved CFTR modulators include lumacaftor/ivacaftor (Orkambi, FDA-approved 2015) for homozygous F508del mutations, tezacaftor/ivacaftor (Symdeko, 2018) for F508del and other mutations, and elexacaftor/tezacaftor/ivacaftor (Trikafta, 2019) for at least one F508del mutation, expanding treatment to ~90% of CF patients.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The next-generation triple combination vanzacaftor/tezacaftor/deutivacaftor (brand name Alyftrek) was approved by the FDA on December 20, 2024, for patients 6 years and older with cystic fibrosis who have at least one responsive CFTR mutation, including 31 additional mutations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Enuka Y, Hanukoglu I, Edelheit O, Vaknine H, Hanukoglu A (March 2012). &quot;Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways&quot;. <em>Histochemistry and Cell Biology</em>. <strong>137</strong> (3): 339â€“353. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs00418-011-0904-1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s00418-011-0904-1</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22207244" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22207244</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:15178940" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15178940</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sharma S, Hanukoglu A, Hanukoglu I (April 2018). &quot;Localization of epithelial sodium channel (ENaC) and CFTR in the germinal epithelium of the testis, Sertoli cells, and spermatozoa&quot;. <em>Journal of Molecular Histology</em>. <strong>49</strong> (2): 195â€“208. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs10735-018-9759-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s10735-018-9759-2</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29453757" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29453757</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:3761720" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3761720</a>.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sharma S, Hanukoglu I (April 2019). &quot;Mapping the sites of localization of epithelial sodium channel (ENaC) and CFTR in segments of the mammalian epididymis&quot;. <em>Journal of Molecular Histology</em>. <strong>50</strong> (2): 141â€“154. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs10735-019-09813-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s10735-019-09813-3</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30659401" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30659401</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:58026884" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">58026884</a>.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sharma S, Kumaran GK, Hanukoglu I (February 2020). &quot;High-resolution imaging of the actin cytoskeleton and epithelial sodium channel, CFTR, and aquaporin-9 localization in the vas deferens&quot;. <em>Mol Reprod Dev</em>. <strong>87</strong> (2): 305â€“319. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fmrd.23317" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/mrd.23317</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31950584" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31950584</a>.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://cysticfibrosisnewstoday.com/2018/08/03/cf-study-finds-new-cells-ionocytes-carrying-high-cftr-levels/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;CF Study Finds New Cells Called Ionocytes Carrying High levels of CFTR Gene&quot;</a>. <em>Cystic Fibrosis News Today</em>. 3 August 2018.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Montoro DT, Haber AL, Biton M, Vinarsky V, Lin B, Birket SE, et al. (August 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295155" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A revised airway epithelial hierarchy includes CFTR-expressing ionocytes&quot;</a>. <em>Nature</em>. <strong>560</strong> (7718): 319â€“324. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2018Natur.560..319M" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2018Natur.560..319M</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fs41586-018-0393-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/s41586-018-0393-7</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295155" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6295155</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30069044" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30069044</a>.</span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Plasschaert LW, Å½ilionis R, Choo-Wing R, Savova V, Knehr J, Roma G, et al. (August 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108322" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte&quot;</a>. <em>Nature</em>. <strong>560</strong> (7718): 377â€“381. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2018Natur.560..377P" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2018Natur.560..377P</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fs41586-018-0394-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/s41586-018-0394-6</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108322" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6108322</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30069046" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30069046</a>.</span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hanukoglu I, Boggula VR, Vaknine H, Sharma S, Kleyman T, Hanukoglu A (June 2017). <a href="https://zenodo.org/record/890756" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Expression of epithelial sodium channel (ENaC) and CFTR in the human epidermis and epidermal appendages&quot;</a>. <em>Histochemistry and Cell Biology</em>. <strong>147</strong> (6): 733â€“748. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs00418-016-1535-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s00418-016-1535-3</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28130590" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28130590</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:8504408" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8504408</a>.</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, et al. (January 2007). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720149" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A novel host defense system of airways is defective in cystic fibrosis&quot;</a>. <em>American Journal of Respiratory and Critical Care Medicine</em>. <strong>175</strong> (2): 174â€“183. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1164%2Frccm.200607-1029OC" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1164/rccm.200607-1029OC</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720149" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2720149</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/17082494" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">17082494</a>.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Xu Y, SzÃ©p S, Lu Z (December 2009). <a href="https://doi.org/10.1073%2Fpnas.0911412106" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>106</strong> (48): 20515â€“20519. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2009PNAS..10620515X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2009PNAS..10620515X</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.0911412106" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.0911412106</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777967" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2777967</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19918082" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19918082</a>.</span></div></li><li id="https://www.cff.org/intro-cf/sweat-test" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cff.org/intro-cf/sweat-test" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cff.org/intro-cf/sweat-test</a></span></div></li><li id="https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626</a></span></div></li><li id="https://hopkinscf.org/knowledge/cftr/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://hopkinscf.org/knowledge/cftr/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://hopkinscf.org/knowledge/cftr/</a></span></div></li><li id="https://cftr2.org/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://cftr2.org/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://cftr2.org/</a></span></div></li><li id="https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.70101" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.70101" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.70101</a></span></div></li><li id="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.678374/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.678374/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.678374/full</a></span></div></li><li id="30" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Shekdar K, Langer J, Venkatachalan S, Schmid L, Anobile J, Shah P, et al. (May 2021). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937778" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cell engineering method using fluorogenic oligonucleotide signaling probes and flow cytometry&quot;</a>. <em>Biotechnology Letters</em>. <strong>43</strong> (5): 949â€“958. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1007%2Fs10529-021-03101-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1007/s10529-021-03101-5</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937778" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7937778</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/33683511" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">33683511</a>.</span></div></li><li id="31" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Rowe SM, Miller S, Sorscher EJ (May 2005). &quot;Cystic fibrosis&quot;. <em>The New England Journal of Medicine</em>. <strong>352</strong> (19): 1992â€“2001. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMra043184" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMra043184</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15888700" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15888700</a>.</span></div></li><li id="32" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kavic SM, Frehm EJ, Segal AS (1999). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Case studies in cholera: lessons in medical history and science&quot;</a>. <em>The Yale Journal of Biology and Medicine</em>. <strong>72</strong> (6): 393â€“408. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2579035</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11138935" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11138935</a>.</span></div></li><li id="33" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://cftr2.org/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;CFTR2&quot;</a>. Retrieved 8 July 2021.</span></div></li><li id="5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">CsanÃ¡dy L, Vergani P, Gadsby DC (January 2019). <a href="https://doi.org/10.1152%2Fphysrev.00007.2018" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Structure, Gating, and Regulation of the CFTR Anion Channel&quot;</a>. <em>Physiological Reviews</em>. <strong>99</strong> (1): 707â€“738. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1152%2Fphysrev.00007.2018" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1152/physrev.00007.2018</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30516439" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30516439</a>.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;cmd=Link&amp;LinkName=gene_pubmed&amp;from_uid=12638" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Mouse PubMed Reference:&quot;</a>. <em>National Center for Biotechnology Information, U.S. National Library of Medicine</em>.</span></div></li><li id="34" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bobadilla JL, Macek M, Fine JP, Farrell PM (June 2002). <a href="https://doi.org/10.1002%2Fhumu.10041" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening&quot;</a>. <em>Human Mutation</em>. <strong>19</strong> (6): 575â€“606. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fhumu.10041" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/humu.10041</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12007216" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12007216</a>.</span></div></li><li id="35" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Verkman AS, Song Y, Thiagarajah JR (January 2003). &quot;Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease&quot;. <em>American Journal of Physiology. Cell Physiology</em>. <strong>284</strong> (1): C2-15. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1152%2Fajpcell.00417.2002" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1152/ajpcell.00417.2002</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12475759" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12475759</a>.</span></div></li><li id="36" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20030525193851/http://www.wrongdiagnosis.com/artic/cystic_fibrosis_research_directions_niddk.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cystic Fibrosis Research Directions&quot;</a>. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Archived from <a href="http://www.wrongdiagnosis.com/artic/cystic_fibrosis_research_directions_niddk.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 25 May 2003.</span></div></li><li id="37" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Boyle MP, De Boeck K (April 2013). &quot;A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect&quot;. <em>The Lancet. Respiratory Medicine</em>. <strong>1</strong> (2): 158â€“163. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fs2213-2600%2812%2970057-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/s2213-2600(12)70057-7</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24429096" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24429096</a>.</span></div></li><li id="38" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Maurya N, Awasthi S, Dixit P (April 2012). <a href="https://web.archive.org/web/20200312193126/https://icmr.nic.in/ijmr/2012/april/0404.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Association of CFTR gene mutation with bronchial asthma&quot;</a> (PDF). <em>The Indian Journal of Medical Research</em>. <strong>135</strong> (4): 469â€“478. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385229" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3385229</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22664493" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22664493</a>. Archived from <a href="http://icmr.nic.in/ijmr/2012/april/0404.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> (PDF) on 12 March 2020. Retrieved 16 March 2019.</span></div></li><li id="39" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?REQUEST=CCDS&amp;DATA=CCDS5773.1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">CCDS Report for Consensus CDS: Report for CCDS5773.1 (current version)</a> NCBI</span></div></li><li id="40" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, et al. (September 2010). <a href="https://doi.org/10.1074%2Fjbc.M110.154575" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>285</strong> (37): 28741â€“28748. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M110.154575" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M110.154575</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937902" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2937902</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20628052" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20628052</a>.</span></div></li><li id="41" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.madsci.org/posts/archives/2000-04/955464305.Me.r.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Re: Is there a connection between cystic fibrosis and cholera?&quot;</a>.</span></div></li><li id="42" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, et al. (May 1998). &quot;Salmonella typhi uses CFTR to enter intestinal epithelial cells&quot;. <em>Nature</em>. <strong>393</strong> (6680): 79â€“82. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1998Natur.393...79P" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1998Natur.393...79P</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2F30006" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/30006</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9590693" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9590693</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:5894247" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5894247</a>.</span></div></li><li id="43" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A (May 2001). <a href="https://doi.org/10.1067%2Fmai.2001.114117" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion&quot;</a>. <em>The Journal of Allergy and Clinical Immunology</em>. <strong>107</strong> (5): 818â€“823. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1067%2Fmai.2001.114117" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1067/mai.2001.114117</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11344348" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11344348</a>.</span></div></li><li id="44" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG (June 1998). &quot;DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma&quot;. <em>Lancet</em>. <strong>351</strong> (9120): 1911â€“1913. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fs0140-6736%2897%2911419-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/s0140-6736(97)11419-2</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9654257" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9654257</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:22970136" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22970136</a>.</span></div></li><li id="45" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wang X, Kim J, McWilliams R, Cutting GR (March 2005). <a href="https://doi.org/10.1001%2Farchotol.131.3.237" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation&quot;</a>. <em>Archives of Otolaryngologyâ€“Head &amp; Neck Surgery</em>. <strong>131</strong> (3): 237â€“240. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchotol.131.3.237" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archotol.131.3.237</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15781764" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15781764</a>.</span></div></li><li id="47" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, GimÃ©nez J, et al. (June 1994). &quot;The origin of the major cystic fibrosis mutation (delta F508) in European populations&quot;. <em>Nature Genetics</em>. <strong>7</strong> (2): 169â€“175. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fng0694-169" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/ng0694-169</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7920636" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7920636</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:38005421" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">38005421</a>.</span></div></li><li id="49" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cystic Fibrosis Mutation Database. <a href="https://web.archive.org/web/20160822142645/http://www.genet.sickkids.on.ca/GenomicDnaSequencePage.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Genomic DNA sequence&quot;</a>. Archived from <a href="http://www.genet.sickkids.on.ca/GenomicDnaSequencePage.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 22 August 2016. Retrieved 6 April 2013.</span></div></li><li id="50" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://hopkinscf.org/knowledge/cftr/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;CFTR&quot;</a>. <em>Johns Hopkins Cystic Fibrosis Center</em>. Retrieved 9 October 2022.</span></div></li><li id="51" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sheppard DN, Welsh MJ (January 1999). <a href="https://doi.org/10.1152%2Fphysrev.1999.79.1.S23" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Structure and function of the CFTR chloride channel&quot;</a>. <em>Physiological Reviews</em>. <strong>79</strong> (1 Suppl): S23 â€“ S45. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1152%2Fphysrev.1999.79.1.S23" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1152/physrev.1999.79.1.S23</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9922375" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9922375</a>.</span></div></li><li id="52" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhang Z, Liu F, Chen J (December 2018). <a href="https://doi.org/10.1073%2Fpnas.1815287115" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Molecular structure of the ATP-bound, phosphorylated human CFTR&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>115</strong> (50): 12757â€“12762. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2018PNAS..11512757Z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2018PNAS..11512757Z</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.1815287115" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.1815287115</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294961" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6294961</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30459277" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30459277</a>.</span></div></li><li id="53" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhang Z, Liu F, Chen J (July 2017). <a href="https://doi.org/10.1016%2Fj.cell.2017.06.041" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Conformational Changes of CFTR upon Phosphorylation and ATP Binding&quot;</a>. <em>Cell</em>. <strong>170</strong> (3): 483â€“491.e8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.cell.2017.06.041" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.cell.2017.06.041</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28735752" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28735752</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:5361509" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5361509</a>.</span></div></li><li id="54" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sheppard DN, Welsh MJ (January 1999). <a href="https://doi.org/10.1152%2Fphysrev.1999.79.1.S23" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Structure and function of the CFTR chloride channel&quot;</a>. <em>Physiological Reviews</em>. <strong>79</strong> (1 Suppl): S23 â€“ S45. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1152%2Fphysrev.1999.79.1.S23" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1152/physrev.1999.79.1.S23</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9922375" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9922375</a>.</span></div></li><li id="55" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, et al. (July 1998). <a href="https://doi.org/10.1074%2Fjbc.273.31.19797" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>273</strong> (31): 19797â€“19801. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.273.31.19797" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.273.31.19797</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9677412" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9677412</a>.</span></div></li><li id="56" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Vergani P, Lockless SW, Nairn AC, Gadsby DC (2005). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756053" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains&quot;</a>. <em>Nature</em>. <strong>433</strong> (7028): 876â€“80. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2005Natur.433..876V" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2005Natur.433..876V</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fnature03313" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/nature03313</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756053" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2756053</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15729345" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15729345</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:4383918" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4383918</a>.</span></div></li><li id="79" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.businesswire.com/news/home/20241220133127/en/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Vertex Announces US FDA Approval of Alyftrek, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis&quot;</a> (Press release). Vertex. 20 December 2024. Retrieved 24 December 2024 â€“ via Business Wire.</span></div></li><li id="58" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Zhang H, Peters KW, Sun F, Marino CR, Lang J, Burgoyne RD, et al. (August 2002). <a href="https://doi.org/10.1074%2Fjbc.M111706200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Cysteine string protein interacts with and modulates the maturation of the cystic fibrosis transmembrane conductance regulator&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>277</strong> (32): 28948â€“28958. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M111706200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M111706200</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12039948" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12039948</a>.</span></div></li><li id="59" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, Mickle JE, et al. (February 2002). <a href="https://doi.org/10.1074%2Fjbc.M110177200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>277</strong> (5): 3520â€“3529. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M110177200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M110177200</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11707463" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11707463</a>.</span></div></li><li id="60" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gentzsch M, Cui L, Mengos A, Chang XB, Chen JH, Riordan JR (February 2003). <a href="https://doi.org/10.1074%2Fjbc.M211050200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>278</strong> (8): 6440â€“6449. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M211050200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M211050200</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12471024" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12471024</a>.</span></div></li><li id="61" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wang S, Yue H, Derin RB, Guggino WB, Li M (September 2000). <a href="https://doi.org/10.1016%2FS0092-8674%2800%2900096-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity&quot;</a>. <em>Cell</em>. <strong>103</strong> (1): 169â€“179. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0092-8674%2800%2900096-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0092-8674(00)00096-9</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11051556" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11051556</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:16697781" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16697781</a>.</span></div></li><li id="62" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Liedtke CM, Yun CH, Kyle N, Wang D (June 2002). <a href="https://doi.org/10.1074%2Fjbc.M201917200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Protein kinase C epsilon-dependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>277</strong> (25): 22925â€“22933. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M201917200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M201917200</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11956211" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11956211</a>.</span></div></li><li id="63" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Park M, Ko SB, Choi JY, Muallem G, Thomas PJ, Pushkin A, et al. (December 2002). <a href="https://doi.org/10.1074%2Fjbc.M201862200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>277</strong> (52): 50503â€“50509. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M201862200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M201862200</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12403779" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12403779</a>.</span></div></li><li id="64" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Cormet-Boyaka E, Di A, Chang SY, Naren AP, Tousson A, Nelson DJ, et al. (September 2002). <a href="https://doi.org/10.1073%2Fpnas.192203899" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>99</strong> (19): 12477â€“12482. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2002PNAS...9912477C" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2002PNAS...9912477C</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.192203899" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.192203899</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC129470" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">129470</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12209004" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12209004</a>.</span></div></li><li id="65" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">HegedÃ¼s T, Sessler T, Scott R, Thelin W, Bakos E, VÃ¡radi A, et al. (March 2003). &quot;C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins&quot;. <em>Biochemical and Biophysical Research Communications</em>. <strong>302</strong> (3): 454â€“461. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2003BBRC..302..454H" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2003BBRC..302..454H</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0006-291X%2803%2900196-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0006-291X(03)00196-7</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/12615054" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">12615054</a>.</span></div></li><li id="66" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Wang S, Raab RW, Schatz PJ, Guggino WB, Li M (May 1998). <a href="https://doi.org/10.1016%2FS0014-5793%2898%2900402-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR)&quot;</a>. <em>FEBS Letters</em>. <strong>427</strong> (1): 103â€“108. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1998FEBSL.427..103W" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1998FEBSL.427..103W</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0014-5793%2898%2900402-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0014-5793(98)00402-5</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9613608" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9613608</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:20803242" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20803242</a>.</span></div></li><li id="67" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Moyer BD, Duhaime M, Shaw C, Denton J, Reynolds D, Karlson KH, et al. (September 2000). <a href="https://doi.org/10.1074%2Fjbc.M004951200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>275</strong> (35): 27069â€“27074. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M004951200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M004951200</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10852925" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10852925</a>.</span></div></li><li id="68" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, Welsh MJ, et al. (July 1998). <a href="https://doi.org/10.1073%2Fpnas.95.15.8496" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins&quot;</a>. <em>Proceedings of the National Academy of Sciences of the United States of America</em>. <strong>95</strong> (15): 8496â€“8501. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1998PNAS...95.8496H" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1998PNAS...95.8496H</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1073%2Fpnas.95.15.8496" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1073/pnas.95.15.8496</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC21104" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21104</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9671706" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9671706</a>.</span></div></li><li id="69" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sun F, Hug MJ, Lewarchik CM, Yun CH, Bradbury NA, Frizzell RA (September 2000). <a href="https://doi.org/10.1074%2Fjbc.M004961200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells&quot;</a>. <em>The Journal of Biological Chemistry</em>. <strong>275</strong> (38): 29539â€“29546. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1074%2Fjbc.M004961200" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1074/jbc.M004961200</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10893422" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10893422</a>.</span></div></li><li id="70" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Naren AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, et al. (November 1997). &quot;Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms&quot;. <em>Nature</em>. <strong>390</strong> (6657): 302â€“305. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1997Natur.390..302N" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1997Natur.390..302N</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2F36882" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/36882</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9384384" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9384384</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:4395005" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4395005</a>.</span></div></li><li id="https://www.cff.org/intro-cf/about-cystic-fibrosis" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cff.org/intro-cf/about-cystic-fibrosis" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cff.org/intro-cf/about-cystic-fibrosis</a></span></div></li><li id="https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00084-2/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00084-2/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00084-2/fulltext</a></span></div></li><li id="73" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Thiagarajah JR, Verkman AS (September 2012). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643514" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;CFTR inhibitors for treating diarrheal disease&quot;</a>. <em>Clinical Pharmacology and Therapeutics</em>. <strong>92</strong> (3): 287â€“290. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fclpt.2012.114" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/clpt.2012.114</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643514" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3643514</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/22850599" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">22850599</a>.</span></div></li><li id="https://www.cysticfibrosisjournal.com/article/S1569-1993(22)00691-9/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cysticfibrosisjournal.com/article/S1569-1993(22)00691-9/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cysticfibrosisjournal.com/article/S1569-1993(22)00691-9/fulltext</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/11344348/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/11344348/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/11344348/</a></span></div></li><li id="75" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">McPhail GL, Clancy JP (April 2013). &quot;Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis&quot;. <em>Drugs of Today</em>. <strong>49</strong> (4): 253â€“260. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1358%2Fdot.2013.49.4.1940984" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1358/dot.2013.49.4.1940984</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23616952" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23616952</a>.</span></div></li><li id="76" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.prnewswire.com/news-releases/phase-3-study-of-vx-770-shows-marked-improvement-in-lung-function-among-people-with-cystic-fibrosis-with-g551d-mutation-116725199.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation&quot;</a> (Press release). Cystic Fibrosis Foundation. 23 February 2011.</span></div></li><li id="77" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Herper M (27 December 2012). <a href="https://www.forbes.com/sites/matthewherper/2012/12/27/the-most-important-new-drug-of-2012/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The Most Important New Drug Of 2012&quot;</a>. <em>Forbes</em>.</span></div></li><li id="78" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Nocera J (18 July 2014). <a href="https://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;The $300,000 Drug&quot;</a>. <em><span class="inline text-[1em] leading-7">The New York Times</span></em>.</span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Cystic_fibrosis_transmembrane_conductance_regulator" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1" id="_R_" async=""></script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Cystic_fibrosis_transmembrane_conductance_regulator\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Cystic_fibrosis_transmembrane_conductance_regulator\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Cystic_fibrosis_transmembrane_conductance_regulator\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T9c8a,"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"# Cystic fibrosis transmembrane conductance regulator\n\n| Available structures | |\n|----------------------|-|\n| [PDB](Protein_Data_Bank \"Protein Data Bank\") | Ortholog search: [PDBe](https://www.ebi.ac.uk/pdbe/searchResults.html?display=both\u0026term=P26361%20or%20P13569) [RCSB](https://www.rcsb.org/search?q=rcsb_polymer_entity_container_identifiers.reference_sequence_identifiers.database_name:UniProt%20AND%20rcsb_polymer_entity_container_identifiers.reference_sequence_identifiers.database_accession:P26361,P13569) |\n\n| List of PDB id codes | |\n|----------------------|-|\n| [1XMI](https://www.rcsb.org/structure/1XMI), [1XMJ](https://www.rcsb.org/structure/1XMJ), [2BBO](https://www.rcsb.org/structure/2BBO), [2BBS](https://www.rcsb.org/structure/2BBS), [2BBT](https://www.rcsb.org/structure/2BBT), [2LOB](https://www.rcsb.org/structure/2LOB), [2PZE](https://www.rcsb.org/structure/2PZE), [2PZF](https://www.rcsb.org/structure/2PZF), [2PZG](https://www.rcsb.org/structure/2PZG), [3GD7](https://www.rcsb.org/structure/3GD7), [3ISW](https://www.rcsb.org/structure/3ISW), [4WZ6](https://www.rcsb.org/structure/4WZ6), [5D2D](https://www.rcsb.org/structure/5D2D), [5D3E](https://www.rcsb.org/structure/5D3E), [5D3F](https://www.rcsb.org/structure/5D3F) |\n\n| Identifiers | |\n|-------------|-|\n| [Aliases](Gene_nomenclature \"Gene nomenclature\") | [CFTR](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/1884), ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-dJ760C5.1, cystic fibrosis transmembrane conductance regulator, CF transmembrane conductance regulator |\n| External IDs | [OMIM](Mendelian_Inheritance_in_Man \"Mendelian Inheritance in Man\"): [602421](https://omim.org/entry/602421); [MGI](Mouse_Genome_Informatics \"Mouse Genome Informatics\"): [88388](http://www.informatics.jax.org/marker/MGI:88388); [HomoloGene](HomoloGene \"HomoloGene\"): [55465](https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve\u0026db=homologene\u0026dopt=HomoloGene\u0026list_uids=55465); [GeneCards](GeneCards \"GeneCards\"): [CFTR](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CFTR); [OMA](Orthologous_MAtrix \"Orthologous MAtrix\"):[CFTR - orthologs](https://omabrowser.org/oma/vps/ENSG00000001626) |\n| [EC number](Enzyme_Commission_number \"Enzyme Commission number\") | [5.6.1.6](https://www.genome.jp/dbget-bin/www_bget?enzyme+5.6.1.6) |\n\n| Gene location ([Human](Human_genome \"Human genome\")) | |\n|-----------------------------------------------------|-|\n| [Chr.](Chromosome \"Chromosome\") | [Chromosome 7 (human)](Chromosome_7_\\(human\\) \"Chromosome 7 \\(human\\)\") |\n| [Band](Locus_\\(genetics\\) \"Locus \\(genetics\\)\") | 7q31.2 |\n| Start | 117,287,120 [bp](Base_pair \"Base pair\") |\n| End | 117,715,971 [bp](Base_pair \"Base pair\") |\n\n| Gene location ([Mouse](Laboratory_mouse \"Laboratory mouse\")) | |\n|--------------------------------------------------------------|-|\n| [Chr.](Chromosome \"Chromosome\") | Chromosome 6 (mouse) |\n| [Band](Locus_\\(genetics\\) \"Locus \\(genetics\\)\") | 6 A2 |\n| 6 8.1 cM | |\n| Start | 18,170,686 [bp](Base_pair \"Base pair\") |\n| End | 18,322,767 [bp](Base_pair \"Base pair\") |\n\n| [RNA expression](Gene_expression \"Gene expression\") pattern | | |\n|------------------------------------------------------------|-|-|\n| [Bgee](https://www.bgee.org/) | | |\n| **[Human](Human_genome \"Human genome\")** | **[Mouse](Laboratory_mouse \"Laboratory mouse\") (ortholog)** | |\n\n| [Top expressed in](https://www.bgee.org/gene/ENSG00000001626) | |\n|---------------------------------------------------------------|-|\n| body of pancreas\u003cbr\u003egallbladder\u003cbr\u003erectum\u003cbr\u003emucosa of sigmoid colon\u003cbr\u003eislet of Langerhans\u003cbr\u003eduodenum\u003cbr\u003emucosa of transverse colon\u003cbr\u003ejejunal mucosa\u003cbr\u003eC1 segment\u003cbr\u003eminor salivary glands |\n\n| [Top expressed in](https://www.bgee.org/gene/ENSMUSG00000041301) | |\n|------------------------------------------------------------------|-|\n| Paneth cell\u003cbr\u003eepithelium of small intestine\u003cbr\u003eIleal epithelium\u003cbr\u003eduodenum\u003cbr\u003eleft colon\u003cbr\u003ecrypt of lieberkuhn of small intestine\u003cbr\u003ejejunum\u003cbr\u003eleft lung lobe\u003cbr\u003emigratory enteric neural crest cell\u003cbr\u003espermatid |\n\n[More reference expression data](https://www.bgee.org/gene/ENSG00000001626)  \n[BioGPS](http://biogps.org/) | n/a\n\n| [Gene ontology](Gene_ontology \"Gene ontology\") | |\n|-----------------------------------------------|-|\n| Molecular function | nucleotide binding (http://amigo.geneontology.org/amigo/term/GO:0000166)\u003cbr\u003ePDZ domain binding (http://amigo.geneontology.org/amigo/term/GO:0030165)\u003cbr\u003echloride transmembrane transporter activity (http://amigo.geneontology.org/amigo/term/GO:0015108)\u003cbr\u003eprotein binding (http://amigo.geneontology.org/amigo/term/GO:0005515)\u003cbr\u003echloride channel inhibitor activity (http://amigo.geneontology.org/amigo/term/GO:0019869)\u003cbr\u003eenzyme binding (http://amigo.geneontology.org/amigo/term/GO:0019899)\u003cbr\u003ehydrolase activity (http://amigo.geneontology.org/amigo/term/GO:0016787)\u003cbr\u003eATP binding (http://amigo.geneontology.org/amigo/term/GO:0005524)\u003cbr\u003echloride channel activity (http://amigo.geneontology.org/amigo/term/GO:0005254)\u003cbr\u003eATPase-coupled inorganic anion transmembrane transporter activity (http://amigo.geneontology.org/amigo/term/GO:0043225)\u003cbr\u003echloride channel regulator activity (http://amigo.geneontology.org/amigo/term/GO:0017081)\u003cbr\u003eATPase-coupled transmembrane transporter activity (http://amigo.geneontology.org/amigo/term/GO:0042626)\u003cbr\u003eintracellularly ATP-gated chloride channel activity (http://amigo.geneontology.org/amigo/term/GO:0005260)\u003cbr\u003eATPase activity (http://amigo.geneontology.org/amigo/term/GO:0016887)\u003cbr\u003ebicarbonate transmembrane transporter activity (http://amigo.geneontology.org/amigo/term/GO:0015106)\u003cbr\u003echaperone binding (http://amigo.geneontology.org/amigo/term/GO:0051087)\u003cbr\u003eSec61 translocon complex binding (http://amigo.geneontology.org/amigo/term/GO:0106138)\u003cbr\u003eisomerase activity (http://amigo.geneontology.org/amigo/term/GO:0016853) |\n| Cellular component | cytoplasm (http://amigo.geneontology.org/amigo/term/GO:0005737)\u003cbr\u003erecycling endosome (http://amigo.geneontology.org/amigo/term/GO:0055037)\u003cbr\u003eendosome (http://amigo.geneontology.org/amigo/term/GO:0005768)\u003cbr\u003eearly endosome membrane (http://amigo.geneontology.org/amigo/term/GO:0031901)\u003cbr\u003emembrane (http://amigo.geneontology.org/amigo/term/GO:0016020)\u003cbr\u003eplasma membrane (http://amigo.geneontology.org/amigo/term/GO:0005886)\u003cbr\u003echloride channel complex (http://amigo.geneontology.org/amigo/term/GO:0034707)\u003cbr\u003ecell surface (http://amigo.geneontology.org/amigo/term/GO:0009986)\u003cbr\u003elysosomal membrane (http://amigo.geneontology.org/amigo/term/GO:0005765)\u003cbr\u003eearly endosome (http://amigo.geneontology.org/amigo/term/GO:0005769)\u003cbr\u003eGolgi-associated vesicle membrane (http://amigo.geneontology.org/amigo/term/GO:0030660)\u003cbr\u003eendoplasmic reticulum Sec complex (http://amigo.geneontology.org/amigo/term/GO:0031205)\u003cbr\u003eextracellular exosome (http://amigo.geneontology.org/amigo/term/GO:0070062)\u003cbr\u003ecytosol (http://amigo.geneontology.org/amigo/term/GO:0005829)\u003cbr\u003eendosome membrane (http://amigo.geneontology.org/amigo/term/GO:0010008)\u003cbr\u003eclathrin-coated vesicle membrane (http://amigo.geneontology.org/amigo/term/GO:0030665)\u003cbr\u003eintegral component of membrane (http://amigo.geneontology.org/amigo/term/GO:0016021)\u003cbr\u003eapical plasma membrane (http://amigo.geneontology.org/amigo/term/GO:0016324)\u003cbr\u003eendoplasmic reticulum (http://amigo.geneontology.org/amigo/term/GO:0005783)\u003cbr\u003eendoplasmic reticulum membrane (http://amigo.geneontology.org/amigo/term/GO:0005789)\u003cbr\u003erecycling endosome membrane (http://amigo.geneontology.org/amigo/term/GO:0055038)\u003cbr\u003eintegral component of plasma membrane (http://amigo.geneontology.org/amigo/term/GO:0005887)\u003cbr\u003enucleus (http://amigo.geneontology.org/amigo/term/GO:0005634)\u003cbr\u003eprotein-containing complex (http://amigo.geneontology.org/amigo/term/GO:0032991) |\n| Biological process | positive regulation of cyclic nucleotide-gated ion channel activity (http://amigo.geneontology.org/amigo/term/GO:1902161)\u003cbr\u003eintracellular pH elevation (http://amigo.geneontology.org/amigo/term/GO:0051454)\u003cbr\u003emembrane hyperpolarization (http://amigo.geneontology.org/amigo/term/GO:0060081)\u003cbr\u003epositive regulation of voltage-gated chloride channel activity (http://amigo.geneontology.org/amigo/term/GO:1902943)\u003cbr\u003echolesterol transport (http://amigo.geneontology.org/amigo/term/GO:0030301)\u003cbr\u003eion transport (http://amigo.geneontology.org/amigo/term/GO:0006811)\u003cbr\u003evesicle docking involved in exocytosis (http://amigo.geneontology.org/amigo/term/GO:0006904)\u003cbr\u003etransmembrane transport (http://amigo.geneontology.org/amigo/term/GO:0055085)\u003cbr\u003esperm capacitation (http://amigo.geneontology.org/amigo/term/GO:0048240)\u003cbr\u003epositive regulation of insulin secretion involved in cellular response to glucose stimulus (http://amigo.geneontology.org/amigo/term/GO:0035774)\u003cbr\u003echolesterol biosynthetic process (http://amigo.geneontology.org/amigo/term/GO:0006695)\u003cbr\u003epositive regulation of exocytosis (http://amigo.geneontology.org/amigo/term/GO:0045921)\u003cbr\u003echloride transport (http://amigo.geneontology.org/amigo/term/GO:0006821)\u003cbr\u003ecellular response to cAMP (http://amigo.geneontology.org/amigo/term/GO:0071320)\u003cbr\u003eprotein deubiquitination (http://amigo.geneontology.org/amigo/term/GO:0016579)\u003cbr\u003emembrane organization (http://amigo.geneontology.org/amigo/term/GO:0061024)\u003cbr\u003echloride transmembrane transport (http://amigo.geneontology.org/amigo/term/GO:1902476)\u003cbr\u003etransepithelial water transport (http://amigo.geneontology.org/amigo/term/GO:0035377)\u003cbr\u003emulticellular organismal water homeostasis (http://amigo.geneontology.org/amigo/term/GO:0050891)\u003cbr\u003ecellular response to forskolin (http://amigo.geneontology.org/amigo/term/GO:1904322)\u003cbr\u003ebicarbonate transport (http://amigo.geneontology.org/amigo/term/GO:0015701)\u003cbr\u003etransport (http://amigo.geneontology.org/amigo/term/GO:0006810)\u003cbr\u003eresponse to endoplasmic reticulum stress (http://amigo.geneontology.org/amigo/term/GO:0034976) |\n| Sources | [Amigo](http://amigo.geneontology.org/) / [QuickGO](https://www.ebi.ac.uk/QuickGO/) |\n\n| [Orthologs](Orthologs \"Orthologs\") | Species | **Human** | **Mouse** |\n|------------------------------------|---------|-----------|-----------|\n| [Entrez](Entrez \"Entrez\") | | [1080](https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene\u0026cmd=retrieve\u0026dopt=default\u0026list_uids=1080\u0026rn=1) | [12638](https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene\u0026cmd=retrieve\u0026dopt=default\u0026list_uids=12638\u0026rn=1) |\n| [Ensembl](Ensembl \"Ensembl\") | | [ENSG00000001626](http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000001626;db=core) | [ENSMUSG00000041301](http://www.ensembl.org/Mus_musculus/geneview?gene=ENSMUSG00000041301;db=core) |\n| [UniProt](UniProt \"UniProt\") | | [P13569](https://www.uniprot.org/uniprot/P13569) | [P26361](https://www.uniprot.org/uniprot/P26361) |\n| RefSeq (mRNA) | | [NM_000492](https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000492) | [NM_021050](https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_021050) |\n| RefSeq (protein) | | [NP_000483](https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000483) | [NP_066388](https://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_066388) |\n| Location (UCSC) | | [Chr 7: 117.29 â€“ 117.72 Mb](https://genome.ucsc.edu/cgi-bin/hgTracks?org=Human\u0026db=hg38\u0026position=chr7:117287120-117715971) | [Chr 6: 18.17 â€“ 18.32 Mb](https://genome.ucsc.edu/cgi-bin/hgTracks?org=Mouse\u0026db=mm0\u0026position=chr6:18170686-18322767) |\n| [PubMed](PubMed \"PubMed\") search | |  |  |\n| [Wikidata](Wikidata \"Wikidata\") | | [View/Edit Human](https://www.wikidata.org/wiki/Q14864712 \"d:Q14864712\") | [View/Edit Mouse](https://www.wikidata.org/wiki/Q14864713 \"d:Q14864713\") |\n\n**Cystic fibrosis transmembrane conductance regulator** (**CFTR**) is a [membrane protein](Membrane_protein \"Membrane protein\") and [anion channel](Anion_channel \"Anion channel\") in vertebrates that is encoded by the _CFTR_ [gene](Gene \"Gene\").\n\nGeneticist Lap-Chee Tsui and his team identified the _CFTR_ gene in 1989 as the gene linked with CF ([cystic fibrosis](Cystic_fibrosis \"Cystic fibrosis\")).\n\nThe _CFTR_ gene codes for an [ABC transporter](ABC_transporter \"ABC transporter\")-class [ion channel](Ion_channel \"Ion channel\") protein that conducts [chloride](Chloride \"Chloride\") and [bicarbonate](Bicarbonate \"Bicarbonate\") ions across [epithelial](Epithelial \"Epithelial\") [cell membranes](Cell_membrane \"Cell membrane\"). Mutations of the _CFTR_ gene affecting anion channel function lead to dysregulation of [epithelial lining fluid](Epithelial_lining_fluid \"Epithelial lining fluid\") (mucus) transport in the lung, pancreas and other organs, resulting in [cystic fibrosis](Cystic_fibrosis \"Cystic fibrosis\"). Complications include thickened [mucus](Mucus \"Mucus\") in the lungs with frequent [respiratory infections](Respiratory_infections \"Respiratory infections\"), and [pancreatic insufficiency](Pancreatic_insufficiency \"Pancreatic insufficiency\") giving rise to malnutrition and [diabetes](Diabetes \"Diabetes\"). These conditions lead to chronic disability and reduced life expectancy. In male patients, the progressive obstruction and destruction of the developing [vas deferens](Vas_deferens \"Vas deferens\") (spermatic cord) and [epididymis](Epididymis \"Epididymis\") appear to result from abnormal intraluminal secretions, causing [congenital absence of the vas deferens](Congenital_absence_of_the_vas_deferens \"Congenital absence of the vas deferens\") and male infertility, and found associated with an imbalance of [fatty acids](Fatty_acid \"Fatty acid\").\n## Tissue and intracellular localization\n\nThe CFTR is found in the epithelial cells of many organs including the lung, liver, pancreas, digestive tract, and the female reproductive tract[12] and male reproductive tract including the testis, Sertoli cells, spermatozoa.[13] epididymis,[14] and the vas deferens.[15]\n\nIn the airways of the lung, CFTR is most highly expressed by rare specialized cells called pulmonary ionocytes.[16][17][18] In the skin, CFTR is strongly expressed in the sebaceous and eccrine sweat glands.[19] In the eccrine glands, CFTR is located on the apical membrane of the epithelial cells that make up the duct of these sweat glands.[19]\n\nNormally, the protein allows movement of chloride, bicarbonate and thiocyanate[20] ions (with a negative charge) out of an epithelial cell into the airway surface liquid and mucus. Positively charged sodium ions follow passively, increasing the total electrolyte concentration in the mucus, resulting in the movement of water out of the cell via osmosis. \n\nIn epithelial cells with motile cilia lining the bronchus and the oviduct, CFTR is located on the apical cell membrane but not on cilia.[12] In contrast, ENaC (Epithelial sodium channel) is located along the entire length of the cilia.[12]\n\nIn sweat glands, defective CFTR results in reduced transport of sodium chloride and sodium thiocyanate[21] in the resorptive duct and therefore saltier sweat. This is the basis of a clinically important sweat test for cystic fibrosis often used diagnostically with genetic screening.[](https://www.cff.org/intro-cf/sweat-test)\n# CFTR gene\n\nThe gene that encodes the human CFTR protein is found on [chromosome 7](Chromosome_7_\\(human\\) \"Chromosome 7 \\(human\\)\"), on the long arm at position q31.2, from base pair 117,287,120 to base pair 117,715,971 (GRCh38.p14). _CFTR_ [orthologs](Orthologs \"Orthologs\") occur in vertebrates, including both jawed and jawless species.[](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626)\n\nEach individual inherits two copies of the _CFTR_ (cystic fibrosis transmembrane conductance regulator) gene. However, some of the inherited copies have been altered. As of 2024, the _CFTR_ gene has been associated with over 2,000 distinct mutations, with approximately 400 classified as CF-causing. An individual with CF inherits two defective copies of the _CFTR_ gene. These mutations might be heterozygous, meaning they include two different mutations, and homozygous, meaning they involve the same mutation. Delta F508 is the most common mutation, accounting for approximately 70% of CF-causing alleles in individuals with cystic fibrosis, particularly in populations of European descent. Those who are homozygous for Delta F508 are commonly affected by pancreatic insufficiency.[](https://hopkinscf.org/knowledge/cftr/)[](https://cftr2.org/)\n\nThe _CFTR_ gene has been used in animals as a [nuclear DNA](Nuclear_DNA \"Nuclear DNA\") phylogenetic marker. Large genomic sequences of this gene have been used to explore the [phylogeny](Phylogeny \"Phylogeny\") of the major groups of [mammals](Mammals \"Mammals\"), and confirmed the grouping of [placental](Placental \"Placental\") orders into four major clades: [Xenarthra](Xenarthra \"Xenarthra\"), [Afrotheria](Afrotheria \"Afrotheria\"), [Laurasiatheria](Laurasiatheria \"Laurasiatheria\"), and [Euarchonta](Euarchonta \"Euarchonta\") plus [Glires](Glires \"Glires\"). \n\n### Mutations\n\nNearly 2,000 cystic fibrosis-associated mutations have been described, with over 400 classified as CF-causing as of 2024. The most common mutation, DeltaF508 (Î”F508) primarily known as a processing mutation which results from a deletion (Î”) of three nucleotides which results in a loss of the amino acid [phenylalanine](Phenylalanine \"Phenylalanine\") (F) at the 508th position on the protein. As a result, the protein does not [fold](Protein_folding \"Protein folding\") normally and is more quickly degraded. The vast majority of mutations are infrequent. The distribution and frequency of mutations varies among different populations which has implications for genetic screening and counseling. DeltaF508 frequency varies globally, reaching ~70% of CF alleles in European-descent populations but lower in Asian and African groups.[](https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.70101)[](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.678374/full)\n\nDrug discovery for therapeutics to address CF in all patients is complicated due to a large number of disease-causing mutations. Ideally, a library of cell lines and cell-based assays corresponding to all mutants is required to screen for broadly-active drug candidates. Cell engineering methods including fluorogenic oligonucleotide signaling probes may be used to detect and isolate clonal cell lines for each mutant.[30]\n\nMutations consist of replacements, duplications, deletions or shortenings in the _CFTR_ gene. This may result in proteins that may not function, work less effectively, are more quickly degraded, or are present in inadequate numbers.[31]\n\nIt has been hypothesized that mutations in the _CFTR_ gene may confer a selective advantage to heterozygous individuals. Cells expressing a mutant form of the CFTR protein are resistant to invasion by the _Salmonella typhi_ bacterium, the agent of [typhoid fever](Typhoid_fever \"Typhoid fever\"), and mice carrying a single copy of mutant _CFTR_ are resistant to diarrhea caused by cholera toxin.[32]\n\nThe most common mutations that cause cystic fibrosis and pancreatic insufficiency in humans are:[33]\n\n| Variant cDNA name (ordered 5' to 3') | Variant protein name | Variant legacy name | rsID | # alleles in CFTR2 | Allele frequency in CFTR2 | % pancreatic insufficient | Variant final determination (as of September 2024) |\n|--------------------------------------|----------------------|---------------------|------|--------------------|---------------------------|---------------------------|---------------------------------------------------|\n| c.1521_1523delCTT | p.Phe508del | F508del | rs113993960 | 99061 | 0.69744 | 98% | CF-causing |\n| c.1624G\u003eT | p.Gly542X | G542X | rs113993959 | 3610 | 0.02542 | 98% | CF-causing |\n| c.1652G\u003eA | p.Gly551Asp | G551D | rs75527207 | 2986 | 0.02102 | 96% | CF-causing |\n| c.3909C\u003eG | p.Asn1303Lys | N1303K | rs80034486 | 2246 | 0.01581 | 98% | CF-causing |\n| c.350G\u003eA | p.Arg117His | R117H | rs78655421 | 1854 | 0.01305 | 23% | Varying clinical consequence |\n| c.3846G\u003eA | p.Trp1282X | W1282X | rs77010898 | 1726 | 0.01215 | 99% | CF-causing |\n| c.489+1G\u003eT | No protein name | 621+1G-\u003eT | rs78756941 | 1323 | 0.00931 | 99% | CF-causing |\n| c.1657C\u003eT | p.Arg553X | R553X | rs74597325 | 1323 | 0.00931 | 97% | CF-causing |\n| c.1585-1G\u003eA | No protein name | 1717-1G-\u003eA | rs76713772 | 1216 | 0.00856 | 97% | CF-causing |\n| c.3718-2477C\u003eT | No protein name | 3849+10kbC-\u003eT | rs75039782 | 1158 | 0.00815 | 33% | CF-causing |\n| c.2657+5G\u003eA | No protein name | 2789+5G-\u003eA | rs80224560 | 1027 | 0.00723 | 43% | CF-causing |\n| c.1519_1521delATC | p. Ile507del | I507del | rs121908745 | 651 | 0.00458 | 98% | CF-causing |\n| c.3484C\u003eT | p.Arg1162X | R1162X | rs74767530 | 651 | 0.00458 | 97% | CF-causing |\n| c.254G\u003eA | p.Gly85Glu | G85E | rs75961395 | 616 | 0.00434 | 85% | CF-causing |\n| c.3454G\u003eC | p.Asp1152His | D1152H | rs75541969 | 571 | 0.00402 | 24% | Varying clinical consequence |\n| c.2051_2052delAAinsG | p. Lys684SerfsX38 | 2183AA-\u003eG | rs121908799 | 542 | 0.00382 | 96% | CF-causing |\n| c.3528delC | p. Lys1177SerfsX15 | 3659delC | rs121908747 | 539 | 0.00379 | 99% | CF-causing |\n| c.1040G\u003eC | p.Arg347Pro | R347P | rs77932196 | 533 | 0.00375 | 68% | CF-causing |\n| c.1210âˆ’12T[5] | No protein name | 5T | rs1805177 | 516 | 0.00363 | 28% | Varying clinical consequence |\n| c.2988+1G\u003eA | No protein name | 3120+1G-\u003eA | rs75096551 | 501 | 0.00353 | 98% | CF-causing |\n| c.1364C\u003eA | p.Ala455Glu | A455E | rs74551128 | 500 | 0.00352 | 34% | CF-causing |\n| c.3140-26A\u003eG | No protein name | 3272-26A-\u003eG | rs76151804 | 470 | 0.00331 | 29% | CF-causing |\n| c.1000C\u003eT | p.Arg334Trp | R334W | rs121909011 | 429 | 0.00302 | 40% | CF-causing |\n| c.1766+1G\u003eA | No protein name | 1898+1G-\u003eA | rs121908748 | 421 | 0.00296 | 99% | CF-causing |\n| c.54-5940_273+10250del21kb | p.Ser18ArgfsX16 | CFTRdele2,3 | not found | 417 | 0.00294 | 100% | CF-causing |\n| c.1679G\u003eC | p.Arg560Thr | R560T | rs80055610 | 343 | 0.00241 | 98% | CF-causing |\n| c.617T\u003eG | p. Leu206Trp | L206W | rs121908752 | 333 | 0.00234 | 20% | CF-causing |\n| c.2052dupA | p.Gln685ThrfsX4 | 2184insA | rs121908786 | 329 | 0.00232 | 85% | CF-causing |\n| c.262_263delTT | p. Leu88IlefsX22 | 394delTT | rs121908769 | 307 | 0.00216 | 97% | CF-causing |\n| c.178G\u003eT | p.Glu60X | E60X | rs77284892 | 296 | 0.00208 | 99% | CF-causing |\n| c.1477C\u003eT | p.Gln493X | Q493X | rs77101217 | 292 | 0.00206 | 98% | CF-causing |\n| c.579+1G\u003eT | No protein name | 711+1G-\u003eT | rs77188391 | 274 | 0.00193 | 98% | CF-causing |\n| c.2052delA | p. Lys684AsnfsX38 | 2184delA | rs121908746 | 255 | 0.00180 | 98% | CF-causing |\n| c.200C\u003eT | p.Pro67Leu | P67L | rs368505753 | 239 | 0.00168 | 34% | CF-causing |\n| c.3302T\u003eA | p.Met1101Lys | M1101K | rs36210737 | 238 | 0.00168 | 69% | CF-causing |\n| c.1408A\u003eG | p.Met470Val | M470V | rs213950 | 235 | 0.00165 | 46% | Non CF-causing |\n| c.3276C\u003eA or c.3276C\u003eG | p.Tyr1092X | Y1092X | rs121908761 | 225 | 0.00158 | 98% | CF-causing |\n| c.3196C\u003eT | p.Arg1066Cys | R1066C | rs78194216 | 220 | 0.00155 | 98% | CF-causing |\n| c.1021_1022dupTC | p.Phe342HisfsX28 | 1154insTC | rs387906360 | 214 | 0.00151 | 99% | CF-causing |\n| c.3773dupT | p. Leu1258PhefsX7 | 3905insT | rs121908789 | 210 | 0.00148 | 97% | CF-causing |\n| c.1646G\u003eA | p.Ser549Asn | S549N | rs121908755 | 203 | 0.00143 | 84% | CF-causing |\n| c.1040G\u003eA | p.Arg347His | R347H | rs77932196 | 199 | 0.00140 | 24% | CF-causing |\n| c.948delT | p.Phe316LeufsX12 | 1078delT | rs121908744 | 184 | 0.00130 | 99% | CF-causing |\n| c.1210-33_1210-6GT[12]T[4] | No protein name | 5T;TG12 | not found | 182 | 0.00128 | 14% | Varying clinical consequence |\n| c.3472C\u003eT | p.Arg1158X | R1158X | rs79850223 | 179 | 0.00126 | 99% | CF-causing |\n| c.2834C\u003eT | p.Ser945Leu | S945L | rs397508442 | 167 | 0.00118 | 40% | CF-causing |\n| c.1558G\u003eT | p. Val520Phe | V520F | rs77646904 | 156 | 0.00110 | 98% | CF-causing |\n| c.443T\u003eC | p. Ile148Thr | I148T | rs35516286 | 148 | 0.00104 | 88% | Non CF-causing |\n| c.349C\u003eT | p.Arg117Cys | R117C | rs77834169 | 146 | 0.00103 | 24% | CF-causing |\n\n### DeltaF508\n\n**DeltaF508** (**Î”F508**), full name **CFTRÎ”F508** or **F508del-CFTR** ([rs113993960](https://www.ncbi.nlm.nih.gov/snp/rs113993960)), is a specific mutation within the CFTR gene involving [deletion](Deletion_\\(genetics\\) \"Deletion \\(genetics\\)\") of three [nucleotides](Nucleotide \"Nucleotide\") spanning codons for amino acid positions 507 and 508 of the CFTR gene on chromosome 7, which ultimately results in the loss of a single [codon](Codon \"Codon\") for the [amino acid](Amino_acid \"Amino acid\") [phenylalanine](Phenylalanine \"Phenylalanine\") (F). A person with the CFTRÎ”F508 mutation will produce an abnormal CFTR protein that lacks this phenylalanine residue and which cannot [fold](Protein_folding \"Protein folding\") properly. Most of this mutated protein does not escape the [endoplasmic reticulum](Endoplasmic_reticulum \"Endoplasmic reticulum\") for further processing. The small amounts that reach the plasma membrane are destabilized and the anion channel opens infrequently. Having two copies of this mutation (one inherited from each parent) is by far the most common cause of [cystic fibrosis](Cystic_fibrosis \"Cystic fibrosis\") (CF), responsible for approximately 70% of CF alleles in patients of European descent, though the frequency is lower worldwide.[34][](https://cftr2.org/)\n\n#### Effects\n\nThe CFTR protein is largely expressed in cells of the pancreas, intestinal and respiratory epithelia, and all exocrine glands. When properly folded, it is shuttled to the cell membrane, where it becomes a transmembrane protein that forms aqueous channels allowing the flow of [chloride](Chloride \"Chloride\") and [bicarbonate](Bicarbonate \"Bicarbonate\") ions out of cells; it also simultaneously inhibits the uptake of [sodium](Sodium \"Sodium\") ions by another channel protein. Both of these functions help to maintain an [ion gradient](Ion_gradient \"Ion gradient\") that causes [osmosis](Osmosis \"Osmosis\") to draw water out of the cells.[35] The Î”F508 mutation leads to the misfolding of CFTR and its eventual [degradation in the ER](Endoplasmic-reticulum-associated_protein_degradation \"Endoplasmic-reticulum-associated protein degradation\"). In organisms with two complements of the mutation, the protein is almost entirely absent from the cell membrane, and these critical ion transport functions are not performed.[36]\n\nHaving a [homozygous](Homozygous \"Homozygous\") pair of genes with the Î”F508 mutation prevents the CFTR protein from assuming its normal position in the cell membrane. This causes increased water retention in cells, corresponding dehydration of the extracellular space, and an associated cascade of effects on various parts of the body. These effects include: thicker [mucous membranes](Mucous_membrane \"Mucous membrane\") in the epithelia of afflicted organs; obstruction of narrow respiratory airways as a result of thicker mucus and inhibition of the free movement of muco cilia; [congenital absence of the vas deferens](Congenital_absence_of_the_vas_deferens \"Congenital absence of the vas deferens\") due to increased mucus thickness during fetal development; pancreatic insufficiency due to blockage of the pancreatic duct with mucus; and increased risk of respiratory infection due to build-up of thick, nutrient-rich mucus where bacteria thrive. These are the symptoms of [cystic fibrosis](Cystic_fibrosis \"Cystic fibrosis\"), a genetic disorder; however, Î”F508 is not the only mutation that causes this disorder.[37]\n\nBeing a [heterozygous](Heterozygous \"Heterozygous\") [carrier](Genetic_carrier \"Genetic carrier\") (having a single copy of Î”F508) results in decreased water loss during [diarrhea](Diarrhea \"Diarrhea\") because malfunctioning or absent CFTR proteins cannot maintain stable ion gradients across cell membranes. Typical nucleotide-binding-up of both Clâ» and Naâº ions inside affected cells, creating a [hypotonic](Tonicity \"Tonicity\") solution outside the cells and causing water to diffuse into the cells by osmosis. Several studies indicate that heterozygous carriers are at increased risk for various symptoms. For example, it has been shown that heterozygosity for cystic fibrosis is associated with increased airway reactivity, and heterozygotes may be at risk for poor pulmonary function. Heterozygotes with wheeze have been shown to be at higher risk for poor pulmonary function or development and progression of chronic [obstructive lung disease](Obstructive_lung_disease \"Obstructive lung disease\"). One gene for cystic fibrosis is sufficient to produce mild lung abnormalities even in the absence of infection.[38]\n\n#### Mechanism\n\nThe _CFTR_ gene is located on the long arm of chromosome 7, at position q31.2, and ultimately codes for a sequence of 1,480 amino acids. Normally, the three [DNA](DNA \"DNA\") [base pairs](Base_pair \"Base pair\") A-T-C (paired with T-A-G on the opposite strand) at the gene's 507th position form the template for the mRNA codon A-U-C for [isoleucine](Isoleucine \"Isoleucine\"), while the three DNA base pairs T-T-T (paired with A-A-A) at the adjacent 508th position form the template for the codon U-U-U for [phenylalanine](Phenylalanine \"Phenylalanine\").[39] The Î”F508 mutation is a deletion of the C-G pair from position 507 along with the first two T-A pairs from position 508, leaving the DNA sequence A-T-T (paired with T-A-A) at position 507, which is [transcribed](Transcription_\\(genetics\\) \"Transcription \\(genetics\\)\") into the mRNA codon A-U-U. Since A-U-U also codes for isoleucine, position 507's amino acid does not change, and the mutation's net effect is equivalent to a deletion (\"Î”\") of the sequence resulting in the codon for phenylalanine at position 508.[40]\n\n#### Prevalence\n\nÎ”F508 is present on at least one copy of chromosome 7 in approximately one in 30 [Caucasians](Caucasoid \"Caucasoid\"). Presence of the mutation on both copies causes the [autosomal recessive](Autosomal_recessive \"Autosomal recessive\") disease cystic fibrosis. Scientists have estimated that the original mutation occurred over 52,000 years ago in Northern [Europe](Europe \"Europe\") though [cystic fibrosis patients of other ethnicities](Cystic_fibrosis_and_race \"Cystic fibrosis and race\") are also known to harbor the mutation. The young [allele age](Allele_age \"Allele age\") may be a consequence of past selection. One hypothesis as to why the otherwise detrimental mutation has been maintained by natural selection is that a single copy may present a positive effect by reducing water loss during [cholera](Cholera \"Cholera\"), though the introduction of pathogenic _[Vibrio cholerae](Vibrio_cholerae \"Vibrio cholerae\")_ into Europe did not occur until the late 18th century.[41] Another theory posits that CF carriers (heterozygotes for Î”F508) are more resistant to [typhoid fever](Typhoid_fever \"Typhoid fever\"), since CFTR has been shown to act as a receptor for _[Salmonella typhi](Salmonella_typhi \"Salmonella typhi\")_ bacteria to enter intestinal epithelial cells.[42]\n\nCystic fibrosis Î”F508 heterozygotes may be overrepresented among individuals with [asthma](Asthma \"Asthma\") and may have poorer lung function than non-carriers.[43][44] Carriers of a single CF mutation have a higher prevalence of chronic [rhinosinusitis](Rhinosinusitis \"Rhinosinusitis\") than the general population.[45] Approximately 50% of cystic fibrosis cases in [Europe](Europe \"Europe\") are due to homozygous Î”F508 mutations (this varies widely by region), while the allele frequency of Î”F508 is about 70%.[47] The remaining cases are caused by over 1,500 other mutations, including R117H, 1717-1G\u003eA, and 2789+56G\u003eA. These mutations, when combined with each other or even a single copy of Î”F508, may cause CF symptoms. The genotype is not strongly correlated with severity of the CF, though specific symptoms have been linked to certain mutations.\n## Structure\n\nThe _CFTR_ gene is approximately 189 [kb](Kilobase_pair \"Kilobase pair\") in length, with 27 [exons](Exons \"Exons\") and 26 [introns](Introns \"Introns\").[49] CFTR is a glycoprotein and is found on the surface of many epithelial cells in the body.[50] CFTR consists of five domains, which include two transmembrane or membrane-spanning domains, two nucleotide-binding domains and a regulatory domain.[51] The transmembrane domains are each connected to a [nucleotide binding domain](ATP-binding_domain_of_ABC_transporters \"ATP-binding domain of ABC transporters\") (NBD) in the cytoplasm. The first NBD is connected to the second transmembrane domain by a regulatory \"R\" domain that is a unique feature of CFTR, not present in other [ABC transporters](ATP-binding_cassette_transporter \"ATP-binding cassette transporter\") which carries 19 predicted sites for protein kinase A(PKA). Six of these have been reported to be phosphorylated in vivo.[52] The ion channel only opens when its R-domain has been phosphorylated by PKA and [ATP](Adenosine_triphosphate \"Adenosine triphosphate\") is bound at the NBDs. Phosphorylation displaces the disordered R domain from positions preventing NBD dimerization and opening.[53][54] The [amino-terminus](N-terminus \"N-terminus\") is part of the lasso motif which anchors into the cell membrane.[52] The [carboxyl terminal](C-terminal_end \"C-terminal end\") of the protein is anchored to the [cytoskeleton](Cytoskeleton \"Cytoskeleton\") by a [PDZ](PDZ_\\(biology\\) \"PDZ \\(biology\\)\")-interacting domain.[55]\n## Location and function\n\nThe CFTR protein is an anion channel that conducts chloride (\\( \\Cl^- \\)) and bicarbonate (\\( \\ce{HCO3^-} \\)) ions across the apical membranes of epithelial cells in various organs, including the lungs, pancreas, and intestines. This ion transport helps regulate the osmotic movement of water. When functioning correctly, as shown in Panel 1, anions flow through open CFTR channels. However, in cystic fibrosis, defective CFTR function impairs anion secretion, leading to osmotic imbalances and thick mucus buildup in affected organs, as illustrated in Panel 2.\n\nThe _CFTR_ gene consists of 27 exons and is located on the long (q) arm of chromosome 7 at position 7q31.2. Exons are the coding segments of the gene that specify the amino acid sequence of the protein.[50] CFTR functions as a phosphorylation- and ATP-gated anion channel that increases conductance for anions such as \\( \\Cl^- \\) and \\( \\ce{HCO3^-} \\), allowing them to flow down their electrochemical gradient. ATP-driven conformational changes in CFTR open and close a gate to permit transmembrane anion flow.[5] This contrasts with other ABC proteins, in which ATP-driven conformational changes drive active transport of substrates against their electrochemical gradient. Essentially, CFTR is an ion channel that evolved from an ABC transporter, functioning as a \"broken\" transporter that permits passive anion leakage in its open conformation. \n\nCFTR consists of five domains: two transmembrane domains (TMD1 and TMD2), two nucleotide-binding domains (NBD1 and NBD2), and a regulatory (R) domain. Other members of the ABC transporter superfamily facilitate nutrient uptake in prokaryotes or export of substrates in eukaryotes. ABC transporters transduce ATP hydrolysis energy to move substrates uphill across membranes. They alternate between inward-facing (ATP-free) and outward-facing (ATP-bound) conformations. ATP binding to the NBDs promotes dimerization, rearranging transmembrane helices and exposing the substrate site outwardly. Subsequent ATP hydrolysis drives the cycle, ensuring unidirectional transport. In CFTR, transitions between inward- and outward-facing conformations control channel gating. Specifically, ATP binding favors NBD dimerization and an outward-facing open pathway for anions.[56] Hydrolysis at the canonical site 2 (in NBD2, involving Walker motifs) destabilizes the dimer, returning to the inward-facing closed state.[5]\n## Clinical implications\n\nMutations in the _CFTR_ gene are classified into six classes (Iâ€“VI) based on their effect on protein production, trafficking, or function, leading to varying degrees of cystic fibrosis (CF) severity.[31] Common manifestations include chronic lung infections, pancreatic insufficiency, and elevated sweat chloride levels (\u003e60 mmol/L, a key diagnostic marker).[31] Mutation-specific therapies, known as CFTR modulators (e.g., ivacaftor for Class III/IV, elexacaftor/tezacaftor/ivacaftor [Trikafta] for Class II like F508del, and vanzacaftor/tezacaftor/deutivacaftor [Alyftrek, approved 2024]), correct underlying defects and improve lung function and quality of life, with median life expectancy now exceeding 50 years as of 2025.[31][79]\n\n### Interactions\n\nThe cystic fibrosis transmembrane conductance regulator has been shown to interact with:\n\n* DNAJC5,[58]\n* GOPC,[59][60]\n* PDZK1,[60][61]\n* PRKCE,[62]\n* SLC4A7,[63]\n* SNAP23,[64]\n* SLC9A3R1,[55][63][65][66][67][68]\n* SLC9A3R2,[69] and\n* STX1A.[64][70]\n\nIt is inhibited by the antidiarrheal drug crofelemer.[Tradtrantip et al. 2009]\n## Related conditions\n\n* [Congenital bilateral absence of the vas deferens](Congenital_bilateral_absence_of_vas_deferens \"Congenital bilateral absence of vas deferens\"): Males with congenital bilateral absence of the [vas deferens](Vas_deferens \"Vas deferens\") most often have a mild [mutation](Mutation \"Mutation\") (a change that allows partial function of the gene) in one copy of the CFTR gene and a cystic fibrosis-causing mutation in the other copy of CFTR.[](https://www.cff.org/intro-cf/about-cystic-fibrosis)\n\n* [Cystic fibrosis](Cystic_fibrosis \"Cystic fibrosis\"): Caused by biallelic pathogenic variants in the CFTR gene (see [[Gene#Mutations]] for details on over 2,000 identified variants, of which ~700 are CF-causing).[](https://cftr2.org/)[](https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00084-2/fulltext)\n\n* [Cholera](Cholera \"Cholera\"): [ADP-ribosylation](ADP-ribosylation \"ADP-ribosylation\") caused by [cholera toxin](Cholera_toxin \"Cholera toxin\") results in increased production of [cyclic AMP](Cyclic_adenosine_monophosphate \"Cyclic adenosine monophosphate\"), which in turn opens the CFTR channel, leading to oversecretion of \\( \\Cl^- \\). \\( \\Na^+ \\) and \\( \\ce{H2O} \\) follow \\( \\Cl^- \\) into the small intestine, resulting in dehydration and loss of electrolytes.[73]\n\n* [CFTR-related disorders](CFTR-related_disorder \"CFTR-related disorder\"): Conditions associated with CFTR dysfunction that do not meet full diagnostic criteria for cystic fibrosis, including idiopathic chronic pancreatitis, disseminated bronchiectasis, and male infertility due to CFTR variants. Heterozygous carriers may have increased risk for chronic rhinosinusitis and asthma.[](https://www.cysticfibrosisjournal.com/article/S1569-1993(22)00691-9/fulltext)[](https://pubmed.ncbi.nlm.nih.gov/11344348/)\n# Drug target\n\nCFTR has been a drug target in efforts to find treatments for cystic fibrosis. [Ivacaftor](https://en.wikipedia.org/wiki/Ivacaftor) (brand name Kalydeco, developed as VX-770) is a medication approved by the FDA on January 31, 2012, for people with cystic fibrosis who have specific CFTR mutations.[75] Ivacaftor was developed by [Vertex Pharmaceuticals](https://en.wikipedia.org/wiki/Vertex_Pharmaceuticals) in conjunction with the [Cystic Fibrosis Foundation](https://en.wikipedia.org/wiki/Cystic_Fibrosis_Foundation) and is the first medication that treats the underlying cause rather than the symptoms of the disease.[76][77] It has been described as \"a wonder drug.\"[78]\n\nOther approved CFTR modulators include lumacaftor/ivacaftor (Orkambi, FDA-approved 2015) for homozygous F508del mutations, tezacaftor/ivacaftor (Symdeko, 2018) for F508del and other mutations, and elexacaftor/tezacaftor/ivacaftor (Trikafta, 2019) for at least one F508del mutation, expanding treatment to ~90% of CF patients.\n\nThe next-generation triple combination vanzacaftor/tezacaftor/deutivacaftor (brand name Alyftrek) was approved by the FDA on December 20, 2024, for patients 6 years and older with cystic fibrosis who have at least one responsive CFTR mutation, including 31 additional mutations.[79]"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761887169725,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"_**a**_ _**b**_ _**c**_ [GRCh38: Ensembl release 89: ENSG00000001626](http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"description\":\"1. ^ _**a**_ _**b**_ _**c**_ [GRCh38: Ensembl release 89: ENSG00000001626](http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"url\":\"http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"_**a**_ _**b**_ _**c**_ [GRCm38: Ensembl release 89: ENSMUSG00000041301](http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000041301) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"description\":\"2. ^ _**a**_ _**b**_ _**c**_ [GRCm38: Ensembl release 89: ENSMUSG00000041301](http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000041301) â€“ [Ensembl](Ensembl_genome_database_project \\\"Ensembl genome database project\\\"), May 2017\",\"url\":\"http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000041301\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"** [\\\"Human PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=1080). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"description\":\"3. **^** [\\\"Human PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=1080). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"url\":\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=1080\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** [\\\"Mouse PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=12638). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"description\":\"4. **^** [\\\"Mouse PubMed Reference:\\\"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=12638). _National Center for Biotechnology Information, U.S. National Library of Medicine_.\",\"url\":\"https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene\u0026cmd=Link\u0026LinkName=gene_pubmed\u0026from_uid=12638\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"_**a**_ _**b**_ _**c**_ CsanÃ¡dy L, Vergani P, Gadsby DC (January 2019). [\\\"Structure, Gating, and Regulation of the CFTR Anion Channel\\\"](https://doi.org/10.1152%2Fphysrev.00007.2018). _Physiological Reviews_. **99** (1): 707â€“738\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.00007.2018](https://doi.org/10.1152%2Fphysrev.00007.2018). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30516439](https://pubmed.ncbi.nlm.nih.gov/30516439).\",\"description\":\"5. ^ _**a**_ _**b**_ _**c**_ CsanÃ¡dy L, Vergani P, Gadsby DC (January 2019). [\\\"Structure, Gating, and Regulation of the CFTR Anion Channel\\\"](https://doi.org/10.1152%2Fphysrev.00007.2018). _Physiological Reviews_. **99** (1): 707â€“738\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.00007.2018](https://doi.org/10.1152%2Fphysrev.00007.2018). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30516439](https://pubmed.ncbi.nlm.nih.gov/30516439).\",\"url\":\"https://doi.org/10.1152%2Fphysrev.00007.2018\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"_**a**_ _**b**_ [Rommens JM](Francis_Collins \\\"Francis Collins\\\"), Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al. (September 1989). \\\"Identification of the cystic fibrosis gene: chromosome walking and jumping\\\". _Science_. **245** (4922): 1059â€“1065\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1989Sci...245.1059R](https://ui.adsabs.harvard.edu/abs/1989Sci...245.1059R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.2772657](https://doi.org/10.1126%2Fscience.2772657). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2772657](https://pubmed.ncbi.nlm.nih.gov/2772657).\",\"description\":\"6. ^ _**a**_ _**b**_ [Rommens JM](Francis_Collins \\\"Francis Collins\\\"), Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al. (September 1989). \\\"Identification of the cystic fibrosis gene: chromosome walking and jumping\\\". _Science_. **245** (4922): 1059â€“1065\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1989Sci...245.1059R](https://ui.adsabs.harvard.edu/abs/1989Sci...245.1059R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.2772657](https://doi.org/10.1126%2Fscience.2772657). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2772657](https://pubmed.ncbi.nlm.nih.gov/2772657).\",\"url\":\"Francis_Collins \\\"Francis Collins\\\"\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** [\\\"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene | The Embryo Project Encyclopedia\\\"](https://embryo.asu.edu/pages/cystic-fibrosis-transmembrane-conductance-regulator-cftr-gene#:~:text=The%20Cystic%20Fibrosis%20Transmembrane%20Conductance,revealed%20the%20underlying%20disease%20mechanism.). _embryo.asu.edu_. Retrieved 26 September 2022.\",\"description\":\"7. **^** [\\\"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene | The Embryo Project Encyclopedia\\\"](https://embryo.asu.edu/pages/cystic-fibrosis-transmembrane-conductance-regulator-cftr-gene#:~:text=The%20Cystic%20Fibrosis%20Transmembrane%20Conductance,revealed%20the%20underlying%20disease%20mechanism.). _embryo.asu.edu_. Retrieved 26 September 2022.\",\"url\":\"https://embryo.asu.edu/pages/cystic-fibrosis-transmembrane-conductance-regulator-cftr-gene#:~:text=The%20Cystic%20Fibrosis%20Transmembrane%20Conductance,revealed%20the%20underlying%20disease%20mechanism.\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"** Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. (September 1989). \\\"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA\\\". _Science_. **245** (4922): 1066â€“1073\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1989Sci...245.1066R](https://ui.adsabs.harvard.edu/abs/1989Sci...245.1066R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.2475911](https://doi.org/10.1126%2Fscience.2475911). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2475911](https://pubmed.ncbi.nlm.nih.gov/2475911). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [84566748](https://api.semanticscholar.org/CorpusID:84566748).\",\"description\":\"8. **^** Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. (September 1989). \\\"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA\\\". _Science_. **245** (4922): 1066â€“1073\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1989Sci...245.1066R](https://ui.adsabs.harvard.edu/abs/1989Sci...245.1066R). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1126/science.2475911](https://doi.org/10.1126%2Fscience.2475911). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2475911](https://pubmed.ncbi.nlm.nih.gov/2475911). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [84566748](https://api.semanticscholar.org/CorpusID:84566748).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. (September 1989). \\\"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA\\\". _Science_. **245** (4922): 1066â€“1073\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0168-9525(89)90155-8](https://doi.org/10.1016%2F0168-9525%2889%2990155-8). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2475911](https://pubmed.ncbi.nlm.nih.gov/2475911).\",\"description\":\"9. **^** Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. (September 1989). \\\"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA\\\". _Science_. **245** (4922): 1066â€“1073\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0168-9525(89)90155-8](https://doi.org/10.1016%2F0168-9525%2889%2990155-8). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [2475911](https://pubmed.ncbi.nlm.nih.gov/2475911).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Marcorelles P, Gillet D, Friocourt G, LedÃ© F, Samaison L, Huguen G, et al. (March 2012). \\\"Cystic fibrosis transmembrane conductance regulator protein expression in the male excretory duct system during development\\\". _Human Pathology_. **43** (3): 390â€“397\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.humpath.2011.04.031](https://doi.org/10.1016%2Fj.humpath.2011.04.031). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21840567](https://pubmed.ncbi.nlm.nih.gov/21840567).\",\"description\":\"10. **^** Marcorelles P, Gillet D, Friocourt G, LedÃ© F, Samaison L, Huguen G, et al. (March 2012). \\\"Cystic fibrosis transmembrane conductance regulator protein expression in the male excretory duct system during development\\\". _Human Pathology_. **43** (3): 390â€“397\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.humpath.2011.04.031](https://doi.org/10.1016%2Fj.humpath.2011.04.031). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21840567](https://pubmed.ncbi.nlm.nih.gov/21840567).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Bregman T, Fride E (June 2011). \\\"Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice\\\". _Journal of Basic and Clinical Physiology and Pharmacology_. **22** (1â€“2): 29â€“32\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1515/jbcpp.2011.004](https://doi.org/10.1515%2Fjbcpp.2011.004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22865360](https://pubmed.ncbi.nlm.nih.gov/22865360). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [19335113](https://api.semanticscholar.org/CorpusID:19335113).\",\"description\":\"11. **^** Bregman T, Fride E (June 2011). \\\"Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice\\\". _Journal of Basic and Clinical Physiology and Pharmacology_. **22** (1â€“2): 29â€“32\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1515/jbcpp.2011.004](https://doi.org/10.1515%2Fjbcpp.2011.004). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22865360](https://pubmed.ncbi.nlm.nih.gov/22865360). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [19335113](https://api.semanticscholar.org/CorpusID:19335113).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"_**a**_ _**b**_ _**c**_ Enuka Y, Hanukoglu I, Edelheit O, Vaknine H, Hanukoglu A (March 2012). \\\"Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways\\\". _Histochemistry and Cell Biology_. **137** (3): 339â€“353\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00418-011-0904-1](https://doi.org/10.1007%2Fs00418-011-0904-1). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22207244](https://pubmed.ncbi.nlm.nih.gov/22207244). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [15178940](https://api.semanticscholar.org/CorpusID:15178940).\",\"description\":\"12. ^ _**a**_ _**b**_ _**c**_ Enuka Y, Hanukoglu I, Edelheit O, Vaknine H, Hanukoglu A (March 2012). \\\"Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways\\\". _Histochemistry and Cell Biology_. **137** (3): 339â€“353\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00418-011-0904-1](https://doi.org/10.1007%2Fs00418-011-0904-1). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22207244](https://pubmed.ncbi.nlm.nih.gov/22207244). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [15178940](https://api.semanticscholar.org/CorpusID:15178940).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** Sharma S, Hanukoglu A, Hanukoglu I (April 2018). \\\"Localization of epithelial sodium channel (ENaC) and CFTR in the germinal epithelium of the testis, Sertoli cells, and spermatozoa\\\". _Journal of Molecular Histology_. **49** (2): 195â€“208\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10735-018-9759-2](https://doi.org/10.1007%2Fs10735-018-9759-2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29453757](https://pubmed.ncbi.nlm.nih.gov/29453757). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [3761720](https://api.semanticscholar.org/CorpusID:3761720).\",\"description\":\"13. **^** Sharma S, Hanukoglu A, Hanukoglu I (April 2018). \\\"Localization of epithelial sodium channel (ENaC) and CFTR in the germinal epithelium of the testis, Sertoli cells, and spermatozoa\\\". _Journal of Molecular Histology_. **49** (2): 195â€“208\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10735-018-9759-2](https://doi.org/10.1007%2Fs10735-018-9759-2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29453757](https://pubmed.ncbi.nlm.nih.gov/29453757). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [3761720](https://api.semanticscholar.org/CorpusID:3761720).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Sharma S, Hanukoglu I (April 2019). \\\"Mapping the sites of localization of epithelial sodium channel (ENaC) and CFTR in segments of the mammalian epididymis\\\". _Journal of Molecular Histology_. **50** (2): 141â€“154\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10735-019-09813-3](https://doi.org/10.1007%2Fs10735-019-09813-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30659401](https://pubmed.ncbi.nlm.nih.gov/30659401). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [58026884](https://api.semanticscholar.org/CorpusID:58026884).\",\"description\":\"14. **^** Sharma S, Hanukoglu I (April 2019). \\\"Mapping the sites of localization of epithelial sodium channel (ENaC) and CFTR in segments of the mammalian epididymis\\\". _Journal of Molecular Histology_. **50** (2): 141â€“154\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10735-019-09813-3](https://doi.org/10.1007%2Fs10735-019-09813-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30659401](https://pubmed.ncbi.nlm.nih.gov/30659401). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [58026884](https://api.semanticscholar.org/CorpusID:58026884).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** Sharma S, Kumaran GK, Hanukoglu I (February 2020). \\\"High-resolution imaging of the actin cytoskeleton and epithelial sodium channel, CFTR, and aquaporin-9 localization in the vas deferens\\\". _Mol Reprod Dev_. **87** (2): 305â€“319\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/mrd.23317](https://doi.org/10.1002%2Fmrd.23317). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31950584](https://pubmed.ncbi.nlm.nih.gov/31950584).\",\"description\":\"15. **^** Sharma S, Kumaran GK, Hanukoglu I (February 2020). \\\"High-resolution imaging of the actin cytoskeleton and epithelial sodium channel, CFTR, and aquaporin-9 localization in the vas deferens\\\". _Mol Reprod Dev_. **87** (2): 305â€“319\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/mrd.23317](https://doi.org/10.1002%2Fmrd.23317). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31950584](https://pubmed.ncbi.nlm.nih.gov/31950584).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** [\\\"CF Study Finds New Cells Called Ionocytes Carrying High levels of CFTR Gene\\\"](https://cysticfibrosisnewstoday.com/2018/08/03/cf-study-finds-new-cells-ionocytes-carrying-high-cftr-levels/). _Cystic Fibrosis News Today_. 3 August 2018.\",\"description\":\"16. **^** [\\\"CF Study Finds New Cells Called Ionocytes Carrying High levels of CFTR Gene\\\"](https://cysticfibrosisnewstoday.com/2018/08/03/cf-study-finds-new-cells-ionocytes-carrying-high-cftr-levels/). _Cystic Fibrosis News Today_. 3 August 2018.\",\"url\":\"https://cysticfibrosisnewstoday.com/2018/08/03/cf-study-finds-new-cells-ionocytes-carrying-high-cftr-levels/\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"** Montoro DT, Haber AL, Biton M, Vinarsky V, Lin B, Birket SE, et al. (August 2018). [\\\"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295155). _Nature_. **560** (7718): 319â€“324\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2018Natur.560..319M](https://ui.adsabs.harvard.edu/abs/2018Natur.560..319M). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41586-018-0393-7](https://doi.org/10.1038%2Fs41586-018-0393-7). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6295155](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295155). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30069044](https://pubmed.ncbi.nlm.nih.gov/30069044).\",\"description\":\"17. **^** Montoro DT, Haber AL, Biton M, Vinarsky V, Lin B, Birket SE, et al. (August 2018). [\\\"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295155). _Nature_. **560** (7718): 319â€“324\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2018Natur.560..319M](https://ui.adsabs.harvard.edu/abs/2018Natur.560..319M). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41586-018-0393-7](https://doi.org/10.1038%2Fs41586-018-0393-7). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6295155](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295155). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30069044](https://pubmed.ncbi.nlm.nih.gov/30069044).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295155\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** Plasschaert LW, Å½ilionis R, Choo-Wing R, Savova V, Knehr J, Roma G, et al. (August 2018). [\\\"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108322). _Nature_. **560** (7718): 377â€“381\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2018Natur.560..377P](https://ui.adsabs.harvard.edu/abs/2018Natur.560..377P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41586-018-0394-6](https://doi.org/10.1038%2Fs41586-018-0394-6). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6108322](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108322). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30069046](https://pubmed.ncbi.nlm.nih.gov/30069046).\",\"description\":\"18. **^** Plasschaert LW, Å½ilionis R, Choo-Wing R, Savova V, Knehr J, Roma G, et al. (August 2018). [\\\"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108322). _Nature_. **560** (7718): 377â€“381\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2018Natur.560..377P](https://ui.adsabs.harvard.edu/abs/2018Natur.560..377P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/s41586-018-0394-6](https://doi.org/10.1038%2Fs41586-018-0394-6). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6108322](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108322). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30069046](https://pubmed.ncbi.nlm.nih.gov/30069046).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108322\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"_**a**_ _**b**_ Hanukoglu I, Boggula VR, Vaknine H, Sharma S, Kleyman T, Hanukoglu A (June 2017). [\\\"Expression of epithelial sodium channel (ENaC) and CFTR in the human epidermis and epidermal appendages\\\"](https://zenodo.org/record/890756). _Histochemistry and Cell Biology_. **147** (6): 733â€“748\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00418-016-1535-3](https://doi.org/10.1007%2Fs00418-016-1535-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28130590](https://pubmed.ncbi.nlm.nih.gov/28130590). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8504408](https://api.semanticscholar.org/CorpusID:8504408).\",\"description\":\"19. ^ _**a**_ _**b**_ Hanukoglu I, Boggula VR, Vaknine H, Sharma S, Kleyman T, Hanukoglu A (June 2017). [\\\"Expression of epithelial sodium channel (ENaC) and CFTR in the human epidermis and epidermal appendages\\\"](https://zenodo.org/record/890756). _Histochemistry and Cell Biology_. **147** (6): 733â€“748\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s00418-016-1535-3](https://doi.org/10.1007%2Fs00418-016-1535-3). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28130590](https://pubmed.ncbi.nlm.nih.gov/28130590). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8504408](https://api.semanticscholar.org/CorpusID:8504408).\",\"url\":\"https://zenodo.org/record/890756\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, et al. (January 2007). [\\\"A novel host defense system of airways is defective in cystic fibrosis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720149). _American Journal of Respiratory and Critical Care Medicine_. **175** (2): 174â€“183\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1164/rccm.200607-1029OC](https://doi.org/10.1164%2Frccm.200607-1029OC). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2720149](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720149). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17082494](https://pubmed.ncbi.nlm.nih.gov/17082494).\",\"description\":\"20. **^** Moskwa P, Lorentzen D, Excoffon KJ, Zabner J, McCray PB, Nauseef WM, et al. (January 2007). [\\\"A novel host defense system of airways is defective in cystic fibrosis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720149). _American Journal of Respiratory and Critical Care Medicine_. **175** (2): 174â€“183\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1164/rccm.200607-1029OC](https://doi.org/10.1164%2Frccm.200607-1029OC). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2720149](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720149). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [17082494](https://pubmed.ncbi.nlm.nih.gov/17082494).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720149\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** Xu Y, SzÃ©p S, Lu Z (December 2009). [\\\"The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases\\\"](https://doi.org/10.1073%2Fpnas.0911412106). _Proceedings of the National Academy of Sciences of the United States of America_. **106** (48): 20515â€“20519\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2009PNAS..10620515X](https://ui.adsabs.harvard.edu/abs/2009PNAS..10620515X). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.0911412106](https://doi.org/10.1073%2Fpnas.0911412106). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2777967](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777967). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19918082](https://pubmed.ncbi.nlm.nih.gov/19918082).\",\"description\":\"21. **^** Xu Y, SzÃ©p S, Lu Z (December 2009). [\\\"The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases\\\"](https://doi.org/10.1073%2Fpnas.0911412106). _Proceedings of the National Academy of Sciences of the United States of America_. **106** (48): 20515â€“20519\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2009PNAS..10620515X](https://ui.adsabs.harvard.edu/abs/2009PNAS..10620515X). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.0911412106](https://doi.org/10.1073%2Fpnas.0911412106). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2777967](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777967). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19918082](https://pubmed.ncbi.nlm.nih.gov/19918082).\",\"url\":\"https://doi.org/10.1073%2Fpnas.0911412106\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** Yonei Y, Tanaka M, Ozawa Y, Miyazaki K, Tsukada N, Inada S, et al. (April 1992). \\\"Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors\\\". _Liver_. **12** (2): 90â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1600-0676.1992.tb00563.x](https://doi.org/10.1111%2Fj.1600-0676.1992.tb00563.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [1320177](https://pubmed.ncbi.nlm.nih.gov/1320177).\",\"description\":\"22. **^** Yonei Y, Tanaka M, Ozawa Y, Miyazaki K, Tsukada N, Inada S, et al. (April 1992). \\\"Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors\\\". _Liver_. **12** (2): 90â€“93\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1600-0676.1992.tb00563.x](https://doi.org/10.1111%2Fj.1600-0676.1992.tb00563.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [1320177](https://pubmed.ncbi.nlm.nih.gov/1320177).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"_**a**_ _**b**_ [\\\"OrthoMaM phylogenetic marker: CFTR coding sequence\\\"](https://web.archive.org/web/20160302164823/http://www.orthomam.univ-montp2.fr/orthomam/data/cds/detailMarkers/ENSG00000001626_CFTR.xml). Archived from [the original](http://www.orthomam.univ-montp2.fr/orthomam/data/cds/detailMarkers/ENSG00000001626_CFTR.xml) on 2 March 2016. Retrieved 12 March 2010.\",\"description\":\"23. ^ _**a**_ _**b**_ [\\\"OrthoMaM phylogenetic marker: CFTR coding sequence\\\"](https://web.archive.org/web/20160302164823/http://www.orthomam.univ-montp2.fr/orthomam/data/cds/detailMarkers/ENSG00000001626_CFTR.xml). Archived from [the original](http://www.orthomam.univ-montp2.fr/orthomam/data/cds/detailMarkers/ENSG00000001626_CFTR.xml) on 2 March 2016. Retrieved 12 March 2010.\",\"url\":\"https://web.archive.org/web/20160302164823/http://www.orthomam.univ-montp2.fr/orthomam/data/cds/detailMarkers/ENSG00000001626_CFTR.xml\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** Davies R, Conroy SJ, Davies WL, Potter IC, Trezise AE (19â€“23 June 2005). [\\\"Evolution and Regulation of the Cystic Fibrosis Gene\\\"](https://espace.library.uq.edu.au/view/UQ:199644) (conference paper). _Molecular Biology and Evolution (MBE05) Conference_. Retrieved 28 July 2014.\",\"description\":\"24. **^** Davies R, Conroy SJ, Davies WL, Potter IC, Trezise AE (19â€“23 June 2005). [\\\"Evolution and Regulation of the Cystic Fibrosis Gene\\\"](https://espace.library.uq.edu.au/view/UQ:199644) (conference paper). _Molecular Biology and Evolution (MBE05) Conference_. Retrieved 28 July 2014.\",\"url\":\"https://espace.library.uq.edu.au/view/UQ:199644\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** Welsh MJ, Smith AE (July 1993). \\\"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis\\\". _Cell_. **73** (7): 1251â€“1254\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0092-8674(93)90353-r](https://doi.org/10.1016%2F0092-8674%2893%2990353-r). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7686820](https://pubmed.ncbi.nlm.nih.gov/7686820).\",\"description\":\"25. **^** Welsh MJ, Smith AE (July 1993). \\\"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis\\\". _Cell_. **73** (7): 1251â€“1254\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0092-8674(93)90353-r](https://doi.org/10.1016%2F0092-8674%2893%2990353-r). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7686820](https://pubmed.ncbi.nlm.nih.gov/7686820).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** [\\\"Genetics and CF\\\"](https://med.stanford.edu/cfcenter/education/english/Genetics.html). _The Cystic Fibrosis Center at Stanford_ (in Samoan). Retrieved 23 October 2022.\",\"description\":\"26. **^** [\\\"Genetics and CF\\\"](https://med.stanford.edu/cfcenter/education/english/Genetics.html). _The Cystic Fibrosis Center at Stanford_ (in Samoan). Retrieved 23 October 2022.\",\"url\":\"https://med.stanford.edu/cfcenter/education/english/Genetics.html\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"** Prasad AB, Allard MW, Green ED (September 2008). [\\\"Confirming the phylogeny of mammals by use of large comparative sequence data sets\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515873). _Molecular Biology and Evolution_. **25** (9): 1795â€“1808\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/molbev/msn104](https://doi.org/10.1093%2Fmolbev%2Fmsn104). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2515873](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515873). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18453548](https://pubmed.ncbi.nlm.nih.gov/18453548).\",\"description\":\"27. **^** Prasad AB, Allard MW, Green ED (September 2008). [\\\"Confirming the phylogeny of mammals by use of large comparative sequence data sets\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515873). _Molecular Biology and Evolution_. **25** (9): 1795â€“1808\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1093/molbev/msn104](https://doi.org/10.1093%2Fmolbev%2Fmsn104). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2515873](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515873). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [18453548](https://pubmed.ncbi.nlm.nih.gov/18453548).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515873\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"** [\\\"The Clinical and Functional TRanslation of CFTR (CFTR2): CFTR2 Variant List History\\\"](https://www.cftr2.org/mutations_history). US CF Foundation, Johns Hopkins University, Cystic Fibrosis Centre at the Hospital for Sick Children in Toronto. Retrieved 2 August 2017.\",\"description\":\"28. **^** [\\\"The Clinical and Functional TRanslation of CFTR (CFTR2): CFTR2 Variant List History\\\"](https://www.cftr2.org/mutations_history). US CF Foundation, Johns Hopkins University, Cystic Fibrosis Centre at the Hospital for Sick Children in Toronto. Retrieved 2 August 2017.\",\"url\":\"https://www.cftr2.org/mutations_history\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"** Guimbellot J, Sharma J, Rowe SM (November 2017). [\\\"Toward inclusive therapy with CFTR modulators: Progress and challenges\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208153). _Pediatric Pulmonology_. **52** (S48): S4 â€“ S14. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ppul.23773](https://doi.org/10.1002%2Fppul.23773). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6208153](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208153). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28881097](https://pubmed.ncbi.nlm.nih.gov/28881097).\",\"description\":\"29. **^** Guimbellot J, Sharma J, Rowe SM (November 2017). [\\\"Toward inclusive therapy with CFTR modulators: Progress and challenges\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208153). _Pediatric Pulmonology_. **52** (S48): S4 â€“ S14. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/ppul.23773](https://doi.org/10.1002%2Fppul.23773). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6208153](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208153). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28881097](https://pubmed.ncbi.nlm.nih.gov/28881097).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208153\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"** Shekdar K, Langer J, Venkatachalan S, Schmid L, Anobile J, Shah P, et al. (May 2021). [\\\"Cell engineering method using fluorogenic oligonucleotide signaling probes and flow cytometry\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937778). _Biotechnology Letters_. **43** (5): 949â€“958\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10529-021-03101-5](https://doi.org/10.1007%2Fs10529-021-03101-5). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7937778](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937778). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [33683511](https://pubmed.ncbi.nlm.nih.gov/33683511).\",\"description\":\"30. **^** Shekdar K, Langer J, Venkatachalan S, Schmid L, Anobile J, Shah P, et al. (May 2021). [\\\"Cell engineering method using fluorogenic oligonucleotide signaling probes and flow cytometry\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937778). _Biotechnology Letters_. **43** (5): 949â€“958\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1007/s10529-021-03101-5](https://doi.org/10.1007%2Fs10529-021-03101-5). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7937778](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937778). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [33683511](https://pubmed.ncbi.nlm.nih.gov/33683511).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937778\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** Rowe SM, Miller S, Sorscher EJ (May 2005). \\\"Cystic fibrosis\\\". _The New England Journal of Medicine_. **352** (19): 1992â€“2001\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMra043184](https://doi.org/10.1056%2FNEJMra043184). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15888700](https://pubmed.ncbi.nlm.nih.gov/15888700).\",\"description\":\"31. **^** Rowe SM, Miller S, Sorscher EJ (May 2005). \\\"Cystic fibrosis\\\". _The New England Journal of Medicine_. **352** (19): 1992â€“2001\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMra043184](https://doi.org/10.1056%2FNEJMra043184). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15888700](https://pubmed.ncbi.nlm.nih.gov/15888700).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"** Kavic SM, Frehm EJ, Segal AS (1999). [\\\"Case studies in cholera: lessons in medical history and science\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579035). _The Yale Journal of Biology and Medicine_. **72** (6): 393â€“408\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2579035](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11138935](https://pubmed.ncbi.nlm.nih.gov/11138935).\",\"description\":\"32. **^** Kavic SM, Frehm EJ, Segal AS (1999). [\\\"Case studies in cholera: lessons in medical history and science\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579035). _The Yale Journal of Biology and Medicine_. **72** (6): 393â€“408\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2579035](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579035). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11138935](https://pubmed.ncbi.nlm.nih.gov/11138935).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579035\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"** [\\\"CFTR2\\\"](https://cftr2.org/). Retrieved 8 July 2021.\",\"description\":\"33. **^** [\\\"CFTR2\\\"](https://cftr2.org/). Retrieved 8 July 2021.\",\"url\":\"https://cftr2.org/\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"** Bobadilla JL, Macek M, Fine JP, Farrell PM (June 2002). [\\\"Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening\\\"](https://doi.org/10.1002%2Fhumu.10041). _Human Mutation_. **19** (6): 575â€“606\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/humu.10041](https://doi.org/10.1002%2Fhumu.10041). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12007216](https://pubmed.ncbi.nlm.nih.gov/12007216).\",\"description\":\"34. **^** Bobadilla JL, Macek M, Fine JP, Farrell PM (June 2002). [\\\"Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening\\\"](https://doi.org/10.1002%2Fhumu.10041). _Human Mutation_. **19** (6): 575â€“606\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/humu.10041](https://doi.org/10.1002%2Fhumu.10041). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12007216](https://pubmed.ncbi.nlm.nih.gov/12007216).\",\"url\":\"https://doi.org/10.1002%2Fhumu.10041\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"** Verkman AS, Song Y, Thiagarajah JR (January 2003). \\\"Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease\\\". _American Journal of Physiology. Cell Physiology_. **284** (1): C2-15. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/ajpcell.00417.2002](https://doi.org/10.1152%2Fajpcell.00417.2002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12475759](https://pubmed.ncbi.nlm.nih.gov/12475759).\",\"description\":\"35. **^** Verkman AS, Song Y, Thiagarajah JR (January 2003). \\\"Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease\\\". _American Journal of Physiology. Cell Physiology_. **284** (1): C2-15. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/ajpcell.00417.2002](https://doi.org/10.1152%2Fajpcell.00417.2002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12475759](https://pubmed.ncbi.nlm.nih.gov/12475759).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"** [\\\"Cystic Fibrosis Research Directions\\\"](https://web.archive.org/web/20030525193851/http://www.wrongdiagnosis.com/artic/cystic_fibrosis_research_directions_niddk.htm). National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Archived from [the original](http://www.wrongdiagnosis.com/artic/cystic_fibrosis_research_directions_niddk.htm) on 25 May 2003.\",\"description\":\"36. **^** [\\\"Cystic Fibrosis Research Directions\\\"](https://web.archive.org/web/20030525193851/http://www.wrongdiagnosis.com/artic/cystic_fibrosis_research_directions_niddk.htm). National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Archived from [the original](http://www.wrongdiagnosis.com/artic/cystic_fibrosis_research_directions_niddk.htm) on 25 May 2003.\",\"url\":\"https://web.archive.org/web/20030525193851/http://www.wrongdiagnosis.com/artic/cystic_fibrosis_research_directions_niddk.htm\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"** Boyle MP, De Boeck K (April 2013). \\\"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect\\\". _The Lancet. Respiratory Medicine_. **1** (2): 158â€“163\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s2213-2600(12)70057-7](https://doi.org/10.1016%2Fs2213-2600%2812%2970057-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24429096](https://pubmed.ncbi.nlm.nih.gov/24429096).\",\"description\":\"37. **^** Boyle MP, De Boeck K (April 2013). \\\"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect\\\". _The Lancet. Respiratory Medicine_. **1** (2): 158â€“163\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s2213-2600(12)70057-7](https://doi.org/10.1016%2Fs2213-2600%2812%2970057-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24429096](https://pubmed.ncbi.nlm.nih.gov/24429096).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"** Maurya N, Awasthi S, Dixit P (April 2012). [\\\"Association of CFTR gene mutation with bronchial asthma\\\"](https://web.archive.org/web/20200312193126/https://icmr.nic.in/ijmr/2012/april/0404.pdf) (PDF). _The Indian Journal of Medical Research_. **135** (4): 469â€“478\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3385229](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385229). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22664493](https://pubmed.ncbi.nlm.nih.gov/22664493). Archived from [the original](http://icmr.nic.in/ijmr/2012/april/0404.pdf) (PDF) on 12 March 2020. Retrieved 16 March 2019.\",\"description\":\"38. **^** Maurya N, Awasthi S, Dixit P (April 2012). [\\\"Association of CFTR gene mutation with bronchial asthma\\\"](https://web.archive.org/web/20200312193126/https://icmr.nic.in/ijmr/2012/april/0404.pdf) (PDF). _The Indian Journal of Medical Research_. **135** (4): 469â€“478\\\\. [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3385229](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385229). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22664493](https://pubmed.ncbi.nlm.nih.gov/22664493). Archived from [the original](http://icmr.nic.in/ijmr/2012/april/0404.pdf) (PDF) on 12 March 2020. Retrieved 16 March 2019.\",\"url\":\"https://web.archive.org/web/20200312193126/https://icmr.nic.in/ijmr/2012/april/0404.pdf\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"** [CCDS Report for Consensus CDS: Report for CCDS5773.1 (current version)](https://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?REQUEST=CCDS\u0026DATA=CCDS5773.1) NCBI\",\"description\":\"39. **^** [CCDS Report for Consensus CDS: Report for CCDS5773.1 (current version)](https://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?REQUEST=CCDS\u0026DATA=CCDS5773.1) NCBI\",\"url\":\"https://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?REQUEST=CCDS\u0026DATA=CCDS5773.1\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"** Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, et al. (September 2010). [\\\"A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein\\\"](https://doi.org/10.1074%2Fjbc.M110.154575). _The Journal of Biological Chemistry_. **285** (37): 28741â€“28748\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M110.154575](https://doi.org/10.1074%2Fjbc.M110.154575). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2937902](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937902). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20628052](https://pubmed.ncbi.nlm.nih.gov/20628052).\",\"description\":\"40. **^** Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, et al. (September 2010). [\\\"A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein\\\"](https://doi.org/10.1074%2Fjbc.M110.154575). _The Journal of Biological Chemistry_. **285** (37): 28741â€“28748\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M110.154575](https://doi.org/10.1074%2Fjbc.M110.154575). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2937902](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937902). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20628052](https://pubmed.ncbi.nlm.nih.gov/20628052).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M110.154575\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"** [\\\"Re: Is there a connection between cystic fibrosis and cholera?\\\"](https://www.madsci.org/posts/archives/2000-04/955464305.Me.r.html).\",\"description\":\"41. **^** [\\\"Re: Is there a connection between cystic fibrosis and cholera?\\\"](https://www.madsci.org/posts/archives/2000-04/955464305.Me.r.html).\",\"url\":\"https://www.madsci.org/posts/archives/2000-04/955464305.Me.r.html\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"** Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, et al. (May 1998). \\\"Salmonella typhi uses CFTR to enter intestinal epithelial cells\\\". _Nature_. **393** (6680): 79â€“82\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1998Natur.393...79P](https://ui.adsabs.harvard.edu/abs/1998Natur.393...79P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/30006](https://doi.org/10.1038%2F30006). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9590693](https://pubmed.ncbi.nlm.nih.gov/9590693). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5894247](https://api.semanticscholar.org/CorpusID:5894247).\",\"description\":\"42. **^** Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, et al. (May 1998). \\\"Salmonella typhi uses CFTR to enter intestinal epithelial cells\\\". _Nature_. **393** (6680): 79â€“82\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1998Natur.393...79P](https://ui.adsabs.harvard.edu/abs/1998Natur.393...79P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/30006](https://doi.org/10.1038%2F30006). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9590693](https://pubmed.ncbi.nlm.nih.gov/9590693). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5894247](https://api.semanticscholar.org/CorpusID:5894247).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"** Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A (May 2001). [\\\"Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion\\\"](https://doi.org/10.1067%2Fmai.2001.114117). _The Journal of Allergy and Clinical Immunology_. **107** (5): 818â€“823\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1067/mai.2001.114117](https://doi.org/10.1067%2Fmai.2001.114117). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11344348](https://pubmed.ncbi.nlm.nih.gov/11344348).\",\"description\":\"43. **^** Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A (May 2001). [\\\"Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion\\\"](https://doi.org/10.1067%2Fmai.2001.114117). _The Journal of Allergy and Clinical Immunology_. **107** (5): 818â€“823\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1067/mai.2001.114117](https://doi.org/10.1067%2Fmai.2001.114117). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11344348](https://pubmed.ncbi.nlm.nih.gov/11344348).\",\"url\":\"https://doi.org/10.1067%2Fmai.2001.114117\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"** Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG (June 1998). \\\"DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma\\\". _Lancet_. **351** (9120): 1911â€“1913\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0140-6736(97)11419-2](https://doi.org/10.1016%2Fs0140-6736%2897%2911419-2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9654257](https://pubmed.ncbi.nlm.nih.gov/9654257). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [22970136](https://api.semanticscholar.org/CorpusID:22970136).\",\"description\":\"44. **^** Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG (June 1998). \\\"DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma\\\". _Lancet_. **351** (9120): 1911â€“1913\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0140-6736(97)11419-2](https://doi.org/10.1016%2Fs0140-6736%2897%2911419-2). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9654257](https://pubmed.ncbi.nlm.nih.gov/9654257). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [22970136](https://api.semanticscholar.org/CorpusID:22970136).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"** Wang X, Kim J, McWilliams R, Cutting GR (March 2005). [\\\"Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation\\\"](https://doi.org/10.1001%2Farchotol.131.3.237). _Archives of Otolaryngologyâ€“Head \u0026 Neck Surgery_. **131** (3): 237â€“240\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archotol.131.3.237](https://doi.org/10.1001%2Farchotol.131.3.237). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15781764](https://pubmed.ncbi.nlm.nih.gov/15781764).\",\"description\":\"45. **^** Wang X, Kim J, McWilliams R, Cutting GR (March 2005). [\\\"Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation\\\"](https://doi.org/10.1001%2Farchotol.131.3.237). _Archives of Otolaryngologyâ€“Head \u0026 Neck Surgery_. **131** (3): 237â€“240\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archotol.131.3.237](https://doi.org/10.1001%2Farchotol.131.3.237). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15781764](https://pubmed.ncbi.nlm.nih.gov/15781764).\",\"url\":\"https://doi.org/10.1001%2Farchotol.131.3.237\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"** [ECFS Annual Report: What It Means to the UK](https://www.cysticfibrosis.org.uk/~/media/documents/the-work-we-do/uk-cf-registry/ecfs-annual-report--what-it-means-to-the-uk-v7.ashx?la=en) [Archived](https://web.archive.org/web/20180501093133/https://www.cysticfibrosis.org.uk/~/media/documents/the-work-we-do/uk-cf-registry/ecfs-annual-report--what-it-means-to-the-uk-v7.ashx?la=en) 1 May 2018 at the [Wayback Machine](Wayback_Machine \\\"Wayback Machine\\\") Cystic Fibrosis Trust\",\"description\":\"46. **^** [ECFS Annual Report: What It Means to the UK](https://www.cysticfibrosis.org.uk/~/media/documents/the-work-we-do/uk-cf-registry/ecfs-annual-report--what-it-means-to-the-uk-v7.ashx?la=en) [Archived](https://web.archive.org/web/20180501093133/https://www.cysticfibrosis.org.uk/~/media/documents/the-work-we-do/uk-cf-registry/ecfs-annual-report--what-it-means-to-the-uk-v7.ashx?la=en) 1 May 2018 at the [Wayback Machine](Wayback_Machine \\\"Wayback Machine\\\") Cystic Fibrosis Trust\",\"url\":\"https://www.cysticfibrosis.org.uk/~/media/documents/the-work-we-do/uk-cf-registry/ecfs-annual-report--what-it-means-to-the-uk-v7.ashx?la=en\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"** Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, GimÃ©nez J, et al. (June 1994). \\\"The origin of the major cystic fibrosis mutation (delta F508) in European populations\\\". _Nature Genetics_. **7** (2): 169â€“175\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng0694-169](https://doi.org/10.1038%2Fng0694-169). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7920636](https://pubmed.ncbi.nlm.nih.gov/7920636). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [38005421](https://api.semanticscholar.org/CorpusID:38005421).\",\"description\":\"47. **^** Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, GimÃ©nez J, et al. (June 1994). \\\"The origin of the major cystic fibrosis mutation (delta F508) in European populations\\\". _Nature Genetics_. **7** (2): 169â€“175\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/ng0694-169](https://doi.org/10.1038%2Fng0694-169). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7920636](https://pubmed.ncbi.nlm.nih.gov/7920636). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [38005421](https://api.semanticscholar.org/CorpusID:38005421).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"** [\\\"5UAK: Dephosphorylated, ATP-free human cystic fibrosis transmembrane conductance regulator (CFTR)\\\"](https://www.rcsb.org/structure/5UAK). _RCSB Protein Data Bank_. 19 December 2016. Retrieved 24 December 2024.\",\"description\":\"48. **^** [\\\"5UAK: Dephosphorylated, ATP-free human cystic fibrosis transmembrane conductance regulator (CFTR)\\\"](https://www.rcsb.org/structure/5UAK). _RCSB Protein Data Bank_. 19 December 2016. Retrieved 24 December 2024.\",\"url\":\"https://www.rcsb.org/structure/5UAK\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"** Cystic Fibrosis Mutation Database. [\\\"Genomic DNA sequence\\\"](https://web.archive.org/web/20160822142645/http://www.genet.sickkids.on.ca/GenomicDnaSequencePage.html). Archived from [the original](http://www.genet.sickkids.on.ca/GenomicDnaSequencePage.html) on 22 August 2016. Retrieved 6 April 2013.\",\"description\":\"49. **^** Cystic Fibrosis Mutation Database. [\\\"Genomic DNA sequence\\\"](https://web.archive.org/web/20160822142645/http://www.genet.sickkids.on.ca/GenomicDnaSequencePage.html). Archived from [the original](http://www.genet.sickkids.on.ca/GenomicDnaSequencePage.html) on 22 August 2016. Retrieved 6 April 2013.\",\"url\":\"https://web.archive.org/web/20160822142645/http://www.genet.sickkids.on.ca/GenomicDnaSequencePage.html\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"_**a**_ _**b**_ [\\\"CFTR\\\"](https://hopkinscf.org/knowledge/cftr/). _Johns Hopkins Cystic Fibrosis Center_. Retrieved 9 October 2022.\",\"description\":\"50. ^ _**a**_ _**b**_ [\\\"CFTR\\\"](https://hopkinscf.org/knowledge/cftr/). _Johns Hopkins Cystic Fibrosis Center_. Retrieved 9 October 2022.\",\"url\":\"https://hopkinscf.org/knowledge/cftr/\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"** Sheppard DN, Welsh MJ (January 1999). [\\\"Structure and function of the CFTR chloride channel\\\"](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). _Physiological Reviews_. **79** (1 Suppl): S23 â€“ S45. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.1999.79.1.S23](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9922375](https://pubmed.ncbi.nlm.nih.gov/9922375).\",\"description\":\"51. **^** Sheppard DN, Welsh MJ (January 1999). [\\\"Structure and function of the CFTR chloride channel\\\"](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). _Physiological Reviews_. **79** (1 Suppl): S23 â€“ S45. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.1999.79.1.S23](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9922375](https://pubmed.ncbi.nlm.nih.gov/9922375).\",\"url\":\"https://doi.org/10.1152%2Fphysrev.1999.79.1.S23\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"_**a**_ _**b**_ Zhang Z, Liu F, Chen J (December 2018). [\\\"Molecular structure of the ATP-bound, phosphorylated human CFTR\\\"](https://doi.org/10.1073%2Fpnas.1815287115). _Proceedings of the National Academy of Sciences of the United States of America_. **115** (50): 12757â€“12762\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2018PNAS..11512757Z](https://ui.adsabs.harvard.edu/abs/2018PNAS..11512757Z). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.1815287115](https://doi.org/10.1073%2Fpnas.1815287115). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6294961](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294961). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30459277](https://pubmed.ncbi.nlm.nih.gov/30459277).\",\"description\":\"52. ^ _**a**_ _**b**_ Zhang Z, Liu F, Chen J (December 2018). [\\\"Molecular structure of the ATP-bound, phosphorylated human CFTR\\\"](https://doi.org/10.1073%2Fpnas.1815287115). _Proceedings of the National Academy of Sciences of the United States of America_. **115** (50): 12757â€“12762\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2018PNAS..11512757Z](https://ui.adsabs.harvard.edu/abs/2018PNAS..11512757Z). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.1815287115](https://doi.org/10.1073%2Fpnas.1815287115). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6294961](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294961). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30459277](https://pubmed.ncbi.nlm.nih.gov/30459277).\",\"url\":\"https://doi.org/10.1073%2Fpnas.1815287115\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"** Zhang Z, Liu F, Chen J (July 2017). [\\\"Conformational Changes of CFTR upon Phosphorylation and ATP Binding\\\"](https://doi.org/10.1016%2Fj.cell.2017.06.041). _Cell_. **170** (3): 483â€“491.e8. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cell.2017.06.041](https://doi.org/10.1016%2Fj.cell.2017.06.041). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28735752](https://pubmed.ncbi.nlm.nih.gov/28735752). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5361509](https://api.semanticscholar.org/CorpusID:5361509).\",\"description\":\"53. **^** Zhang Z, Liu F, Chen J (July 2017). [\\\"Conformational Changes of CFTR upon Phosphorylation and ATP Binding\\\"](https://doi.org/10.1016%2Fj.cell.2017.06.041). _Cell_. **170** (3): 483â€“491.e8. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.cell.2017.06.041](https://doi.org/10.1016%2Fj.cell.2017.06.041). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28735752](https://pubmed.ncbi.nlm.nih.gov/28735752). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5361509](https://api.semanticscholar.org/CorpusID:5361509).\",\"url\":\"https://doi.org/10.1016%2Fj.cell.2017.06.041\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"** Sheppard DN, Welsh MJ (January 1999). [\\\"Structure and function of the CFTR chloride channel\\\"](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). _Physiological Reviews_. **79** (1 Suppl): S23 â€“ S45. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.1999.79.1.S23](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9922375](https://pubmed.ncbi.nlm.nih.gov/9922375).\",\"description\":\"54. **^** Sheppard DN, Welsh MJ (January 1999). [\\\"Structure and function of the CFTR chloride channel\\\"](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). _Physiological Reviews_. **79** (1 Suppl): S23 â€“ S45. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.1999.79.1.S23](https://doi.org/10.1152%2Fphysrev.1999.79.1.S23). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9922375](https://pubmed.ncbi.nlm.nih.gov/9922375).\",\"url\":\"https://doi.org/10.1152%2Fphysrev.1999.79.1.S23\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"_**a**_ _**b**_ Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, et al. (July 1998). [\\\"An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton\\\"](https://doi.org/10.1074%2Fjbc.273.31.19797). _The Journal of Biological Chemistry_. **273** (31): 19797â€“19801\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.273.31.19797](https://doi.org/10.1074%2Fjbc.273.31.19797). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9677412](https://pubmed.ncbi.nlm.nih.gov/9677412).\",\"description\":\"55. ^ _**a**_ _**b**_ Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, et al. (July 1998). [\\\"An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton\\\"](https://doi.org/10.1074%2Fjbc.273.31.19797). _The Journal of Biological Chemistry_. **273** (31): 19797â€“19801\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.273.31.19797](https://doi.org/10.1074%2Fjbc.273.31.19797). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9677412](https://pubmed.ncbi.nlm.nih.gov/9677412).\",\"url\":\"https://doi.org/10.1074%2Fjbc.273.31.19797\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"** Vergani P, Lockless SW, Nairn AC, Gadsby DC (2005). [\\\"CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756053). _Nature_. **433** (7028): 876â€“80\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2005Natur.433..876V](https://ui.adsabs.harvard.edu/abs/2005Natur.433..876V). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature03313](https://doi.org/10.1038%2Fnature03313). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2756053](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756053). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15729345](https://pubmed.ncbi.nlm.nih.gov/15729345). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4383918](https://api.semanticscholar.org/CorpusID:4383918).\",\"description\":\"56. **^** Vergani P, Lockless SW, Nairn AC, Gadsby DC (2005). [\\\"CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756053). _Nature_. **433** (7028): 876â€“80\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2005Natur.433..876V](https://ui.adsabs.harvard.edu/abs/2005Natur.433..876V). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/nature03313](https://doi.org/10.1038%2Fnature03313). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2756053](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756053). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15729345](https://pubmed.ncbi.nlm.nih.gov/15729345). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4383918](https://api.semanticscholar.org/CorpusID:4383918).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756053\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"** Boyle MP, De Boeck K (April 2013). \\\"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect\\\". _The Lancet. Respiratory Medicine_. **1** (2): 158â€“163\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s2213-2600(12)70057-7](https://doi.org/10.1016%2Fs2213-2600%2812%2970057-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24429096](https://pubmed.ncbi.nlm.nih.gov/24429096).\",\"description\":\"57. **^** Boyle MP, De Boeck K (April 2013). \\\"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect\\\". _The Lancet. Respiratory Medicine_. **1** (2): 158â€“163\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s2213-2600(12)70057-7](https://doi.org/10.1016%2Fs2213-2600%2812%2970057-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24429096](https://pubmed.ncbi.nlm.nih.gov/24429096).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"** Zhang H, Peters KW, Sun F, Marino CR, Lang J, Burgoyne RD, et al. (August 2002). [\\\"Cysteine string protein interacts with and modulates the maturation of the cystic fibrosis transmembrane conductance regulator\\\"](https://doi.org/10.1074%2Fjbc.M111706200). _The Journal of Biological Chemistry_. **277** (32): 28948â€“28958\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M111706200](https://doi.org/10.1074%2Fjbc.M111706200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12039948](https://pubmed.ncbi.nlm.nih.gov/12039948).\",\"description\":\"58. **^** Zhang H, Peters KW, Sun F, Marino CR, Lang J, Burgoyne RD, et al. (August 2002). [\\\"Cysteine string protein interacts with and modulates the maturation of the cystic fibrosis transmembrane conductance regulator\\\"](https://doi.org/10.1074%2Fjbc.M111706200). _The Journal of Biological Chemistry_. **277** (32): 28948â€“28958\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M111706200](https://doi.org/10.1074%2Fjbc.M111706200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12039948](https://pubmed.ncbi.nlm.nih.gov/12039948).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M111706200\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"** Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, Mickle JE, et al. (February 2002). [\\\"A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression\\\"](https://doi.org/10.1074%2Fjbc.M110177200). _The Journal of Biological Chemistry_. **277** (5): 3520â€“3529\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M110177200](https://doi.org/10.1074%2Fjbc.M110177200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11707463](https://pubmed.ncbi.nlm.nih.gov/11707463).\",\"description\":\"59. **^** Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, Mickle JE, et al. (February 2002). [\\\"A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression\\\"](https://doi.org/10.1074%2Fjbc.M110177200). _The Journal of Biological Chemistry_. **277** (5): 3520â€“3529\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M110177200](https://doi.org/10.1074%2Fjbc.M110177200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11707463](https://pubmed.ncbi.nlm.nih.gov/11707463).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M110177200\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"_**a**_ _**b**_ Gentzsch M, Cui L, Mengos A, Chang XB, Chen JH, Riordan JR (February 2003). [\\\"The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins\\\"](https://doi.org/10.1074%2Fjbc.M211050200). _The Journal of Biological Chemistry_. **278** (8): 6440â€“6449\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M211050200](https://doi.org/10.1074%2Fjbc.M211050200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12471024](https://pubmed.ncbi.nlm.nih.gov/12471024).\",\"description\":\"60. ^ _**a**_ _**b**_ Gentzsch M, Cui L, Mengos A, Chang XB, Chen JH, Riordan JR (February 2003). [\\\"The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins\\\"](https://doi.org/10.1074%2Fjbc.M211050200). _The Journal of Biological Chemistry_. **278** (8): 6440â€“6449\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M211050200](https://doi.org/10.1074%2Fjbc.M211050200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12471024](https://pubmed.ncbi.nlm.nih.gov/12471024).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M211050200\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"** Wang S, Yue H, Derin RB, Guggino WB, Li M (September 2000). [\\\"Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity\\\"](https://doi.org/10.1016%2FS0092-8674%2800%2900096-9). _Cell_. **103** (1): 169â€“179\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0092-8674(00)00096-9](https://doi.org/10.1016%2FS0092-8674%2800%2900096-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11051556](https://pubmed.ncbi.nlm.nih.gov/11051556). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [16697781](https://api.semanticscholar.org/CorpusID:16697781).\",\"description\":\"61. **^** Wang S, Yue H, Derin RB, Guggino WB, Li M (September 2000). [\\\"Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity\\\"](https://doi.org/10.1016%2FS0092-8674%2800%2900096-9). _Cell_. **103** (1): 169â€“179\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0092-8674(00)00096-9](https://doi.org/10.1016%2FS0092-8674%2800%2900096-9). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11051556](https://pubmed.ncbi.nlm.nih.gov/11051556). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [16697781](https://api.semanticscholar.org/CorpusID:16697781).\",\"url\":\"https://doi.org/10.1016%2FS0092-8674%2800%2900096-9\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"** Liedtke CM, Yun CH, Kyle N, Wang D (June 2002). [\\\"Protein kinase C epsilon-dependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor\\\"](https://doi.org/10.1074%2Fjbc.M201917200). _The Journal of Biological Chemistry_. **277** (25): 22925â€“22933\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M201917200](https://doi.org/10.1074%2Fjbc.M201917200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11956211](https://pubmed.ncbi.nlm.nih.gov/11956211).\",\"description\":\"62. **^** Liedtke CM, Yun CH, Kyle N, Wang D (June 2002). [\\\"Protein kinase C epsilon-dependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor\\\"](https://doi.org/10.1074%2Fjbc.M201917200). _The Journal of Biological Chemistry_. **277** (25): 22925â€“22933\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M201917200](https://doi.org/10.1074%2Fjbc.M201917200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11956211](https://pubmed.ncbi.nlm.nih.gov/11956211).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M201917200\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"_**a**_ _**b**_ Park M, Ko SB, Choi JY, Muallem G, Thomas PJ, Pushkin A, et al. (December 2002). [\\\"The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3\\\"](https://doi.org/10.1074%2Fjbc.M201862200). _The Journal of Biological Chemistry_. **277** (52): 50503â€“50509\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M201862200](https://doi.org/10.1074%2Fjbc.M201862200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12403779](https://pubmed.ncbi.nlm.nih.gov/12403779).\",\"description\":\"63. ^ _**a**_ _**b**_ Park M, Ko SB, Choi JY, Muallem G, Thomas PJ, Pushkin A, et al. (December 2002). [\\\"The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3\\\"](https://doi.org/10.1074%2Fjbc.M201862200). _The Journal of Biological Chemistry_. **277** (52): 50503â€“50509\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M201862200](https://doi.org/10.1074%2Fjbc.M201862200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12403779](https://pubmed.ncbi.nlm.nih.gov/12403779).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M201862200\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"_**a**_ _**b**_ Cormet-Boyaka E, Di A, Chang SY, Naren AP, Tousson A, Nelson DJ, et al. (September 2002). [\\\"CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex\\\"](https://doi.org/10.1073%2Fpnas.192203899). _Proceedings of the National Academy of Sciences of the United States of America_. **99** (19): 12477â€“12482\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2002PNAS...9912477C](https://ui.adsabs.harvard.edu/abs/2002PNAS...9912477C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.192203899](https://doi.org/10.1073%2Fpnas.192203899). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [129470](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC129470). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12209004](https://pubmed.ncbi.nlm.nih.gov/12209004).\",\"description\":\"64. ^ _**a**_ _**b**_ Cormet-Boyaka E, Di A, Chang SY, Naren AP, Tousson A, Nelson DJ, et al. (September 2002). [\\\"CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex\\\"](https://doi.org/10.1073%2Fpnas.192203899). _Proceedings of the National Academy of Sciences of the United States of America_. **99** (19): 12477â€“12482\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2002PNAS...9912477C](https://ui.adsabs.harvard.edu/abs/2002PNAS...9912477C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.192203899](https://doi.org/10.1073%2Fpnas.192203899). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [129470](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC129470). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12209004](https://pubmed.ncbi.nlm.nih.gov/12209004).\",\"url\":\"https://doi.org/10.1073%2Fpnas.192203899\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"** HegedÃ¼s T, Sessler T, Scott R, Thelin W, Bakos E, VÃ¡radi A, et al. (March 2003). \\\"C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins\\\". _Biochemical and Biophysical Research Communications_. **302** (3): 454â€“461\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2003BBRC..302..454H](https://ui.adsabs.harvard.edu/abs/2003BBRC..302..454H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0006-291X(03)00196-7](https://doi.org/10.1016%2FS0006-291X%2803%2900196-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12615054](https://pubmed.ncbi.nlm.nih.gov/12615054).\",\"description\":\"65. **^** HegedÃ¼s T, Sessler T, Scott R, Thelin W, Bakos E, VÃ¡radi A, et al. (March 2003). \\\"C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins\\\". _Biochemical and Biophysical Research Communications_. **302** (3): 454â€“461\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2003BBRC..302..454H](https://ui.adsabs.harvard.edu/abs/2003BBRC..302..454H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0006-291X(03)00196-7](https://doi.org/10.1016%2FS0006-291X%2803%2900196-7). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [12615054](https://pubmed.ncbi.nlm.nih.gov/12615054).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"** Wang S, Raab RW, Schatz PJ, Guggino WB, Li M (May 1998). [\\\"Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR)\\\"](https://doi.org/10.1016%2FS0014-5793%2898%2900402-5). _FEBS Letters_. **427** (1): 103â€“108\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1998FEBSL.427..103W](https://ui.adsabs.harvard.edu/abs/1998FEBSL.427..103W). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0014-5793(98)00402-5](https://doi.org/10.1016%2FS0014-5793%2898%2900402-5). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9613608](https://pubmed.ncbi.nlm.nih.gov/9613608). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20803242](https://api.semanticscholar.org/CorpusID:20803242).\",\"description\":\"66. **^** Wang S, Raab RW, Schatz PJ, Guggino WB, Li M (May 1998). [\\\"Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR)\\\"](https://doi.org/10.1016%2FS0014-5793%2898%2900402-5). _FEBS Letters_. **427** (1): 103â€“108\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1998FEBSL.427..103W](https://ui.adsabs.harvard.edu/abs/1998FEBSL.427..103W). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0014-5793(98)00402-5](https://doi.org/10.1016%2FS0014-5793%2898%2900402-5). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9613608](https://pubmed.ncbi.nlm.nih.gov/9613608). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20803242](https://api.semanticscholar.org/CorpusID:20803242).\",\"url\":\"https://doi.org/10.1016%2FS0014-5793%2898%2900402-5\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"** Moyer BD, Duhaime M, Shaw C, Denton J, Reynolds D, Karlson KH, et al. (September 2000). [\\\"The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane\\\"](https://doi.org/10.1074%2Fjbc.M004951200). _The Journal of Biological Chemistry_. **275** (35): 27069â€“27074\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M004951200](https://doi.org/10.1074%2Fjbc.M004951200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10852925](https://pubmed.ncbi.nlm.nih.gov/10852925).\",\"description\":\"67. **^** Moyer BD, Duhaime M, Shaw C, Denton J, Reynolds D, Karlson KH, et al. (September 2000). [\\\"The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane\\\"](https://doi.org/10.1074%2Fjbc.M004951200). _The Journal of Biological Chemistry_. **275** (35): 27069â€“27074\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M004951200](https://doi.org/10.1074%2Fjbc.M004951200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10852925](https://pubmed.ncbi.nlm.nih.gov/10852925).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M004951200\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"** Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, Welsh MJ, et al. (July 1998). [\\\"A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins\\\"](https://doi.org/10.1073%2Fpnas.95.15.8496). _Proceedings of the National Academy of Sciences of the United States of America_. **95** (15): 8496â€“8501\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1998PNAS...95.8496H](https://ui.adsabs.harvard.edu/abs/1998PNAS...95.8496H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.95.15.8496](https://doi.org/10.1073%2Fpnas.95.15.8496). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [21104](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC21104). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9671706](https://pubmed.ncbi.nlm.nih.gov/9671706).\",\"description\":\"68. **^** Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, Welsh MJ, et al. (July 1998). [\\\"A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins\\\"](https://doi.org/10.1073%2Fpnas.95.15.8496). _Proceedings of the National Academy of Sciences of the United States of America_. **95** (15): 8496â€“8501\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1998PNAS...95.8496H](https://ui.adsabs.harvard.edu/abs/1998PNAS...95.8496H). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1073/pnas.95.15.8496](https://doi.org/10.1073%2Fpnas.95.15.8496). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [21104](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC21104). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9671706](https://pubmed.ncbi.nlm.nih.gov/9671706).\",\"url\":\"https://doi.org/10.1073%2Fpnas.95.15.8496\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"** Sun F, Hug MJ, Lewarchik CM, Yun CH, Bradbury NA, Frizzell RA (September 2000). [\\\"E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells\\\"](https://doi.org/10.1074%2Fjbc.M004961200). _The Journal of Biological Chemistry_. **275** (38): 29539â€“29546\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M004961200](https://doi.org/10.1074%2Fjbc.M004961200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10893422](https://pubmed.ncbi.nlm.nih.gov/10893422).\",\"description\":\"69. **^** Sun F, Hug MJ, Lewarchik CM, Yun CH, Bradbury NA, Frizzell RA (September 2000). [\\\"E3KARP mediates the association of ezrin and protein kinase A with the cystic fibrosis transmembrane conductance regulator in airway cells\\\"](https://doi.org/10.1074%2Fjbc.M004961200). _The Journal of Biological Chemistry_. **275** (38): 29539â€“29546\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1074/jbc.M004961200](https://doi.org/10.1074%2Fjbc.M004961200). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10893422](https://pubmed.ncbi.nlm.nih.gov/10893422).\",\"url\":\"https://doi.org/10.1074%2Fjbc.M004961200\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"** Naren AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, et al. (November 1997). \\\"Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms\\\". _Nature_. **390** (6657): 302â€“305\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1997Natur.390..302N](https://ui.adsabs.harvard.edu/abs/1997Natur.390..302N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/36882](https://doi.org/10.1038%2F36882). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9384384](https://pubmed.ncbi.nlm.nih.gov/9384384). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4395005](https://api.semanticscholar.org/CorpusID:4395005).\",\"description\":\"70. **^** Naren AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, et al. (November 1997). \\\"Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms\\\". _Nature_. **390** (6657): 302â€“305\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1997Natur.390..302N](https://ui.adsabs.harvard.edu/abs/1997Natur.390..302N). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/36882](https://doi.org/10.1038%2F36882). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9384384](https://pubmed.ncbi.nlm.nih.gov/9384384). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [4395005](https://api.semanticscholar.org/CorpusID:4395005).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"** Egan ME (March 2016). \\\"Genetics of Cystic Fibrosis: Clinical Implications\\\". _Clinics in Chest Medicine_. **37** (1): 9â€“16\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ccm.2015.11.002](https://doi.org/10.1016%2Fj.ccm.2015.11.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26857764](https://pubmed.ncbi.nlm.nih.gov/26857764).\",\"description\":\"71. **^** Egan ME (March 2016). \\\"Genetics of Cystic Fibrosis: Clinical Implications\\\". _Clinics in Chest Medicine_. **37** (1): 9â€“16\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ccm.2015.11.002](https://doi.org/10.1016%2Fj.ccm.2015.11.002). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26857764](https://pubmed.ncbi.nlm.nih.gov/26857764).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"** De Boeck K, Amaral MD (August 2016). \\\"Progress in therapies for cystic fibrosis\\\". _The Lancet. Respiratory Medicine_. **4** (8): 662â€“674\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S2213-2600(16)00023-0](https://doi.org/10.1016%2FS2213-2600%2816%2900023-0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27053340](https://pubmed.ncbi.nlm.nih.gov/27053340).\",\"description\":\"72. **^** De Boeck K, Amaral MD (August 2016). \\\"Progress in therapies for cystic fibrosis\\\". _The Lancet. Respiratory Medicine_. **4** (8): 662â€“674\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S2213-2600(16)00023-0](https://doi.org/10.1016%2FS2213-2600%2816%2900023-0). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27053340](https://pubmed.ncbi.nlm.nih.gov/27053340).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"** Thiagarajah JR, Verkman AS (September 2012). [\\\"CFTR inhibitors for treating diarrheal disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643514). _Clinical Pharmacology and Therapeutics_. **92** (3): 287â€“290\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/clpt.2012.114](https://doi.org/10.1038%2Fclpt.2012.114). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3643514](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643514). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22850599](https://pubmed.ncbi.nlm.nih.gov/22850599).\",\"description\":\"73. **^** Thiagarajah JR, Verkman AS (September 2012). [\\\"CFTR inhibitors for treating diarrheal disease\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643514). _Clinical Pharmacology and Therapeutics_. **92** (3): 287â€“290\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/clpt.2012.114](https://doi.org/10.1038%2Fclpt.2012.114). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3643514](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643514). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [22850599](https://pubmed.ncbi.nlm.nih.gov/22850599).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643514\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"** Jones AM, Helm JM (October 2009). \\\"Emerging treatments in cystic fibrosis\\\". _Drugs_. **69** (14): 1903â€“1910\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2165/11318500-000000000-00000](https://doi.org/10.2165%2F11318500-000000000-00000). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19747007](https://pubmed.ncbi.nlm.nih.gov/19747007). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [23344660](https://api.semanticscholar.org/CorpusID:23344660).\",\"description\":\"74. **^** Jones AM, Helm JM (October 2009). \\\"Emerging treatments in cystic fibrosis\\\". _Drugs_. **69** (14): 1903â€“1910\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2165/11318500-000000000-00000](https://doi.org/10.2165%2F11318500-000000000-00000). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19747007](https://pubmed.ncbi.nlm.nih.gov/19747007). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [23344660](https://api.semanticscholar.org/CorpusID:23344660).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"** McPhail GL, Clancy JP (April 2013). \\\"Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis\\\". _Drugs of Today_. **49** (4): 253â€“260\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1358/dot.2013.49.4.1940984](https://doi.org/10.1358%2Fdot.2013.49.4.1940984). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23616952](https://pubmed.ncbi.nlm.nih.gov/23616952).\",\"description\":\"75. **^** McPhail GL, Clancy JP (April 2013). \\\"Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis\\\". _Drugs of Today_. **49** (4): 253â€“260\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1358/dot.2013.49.4.1940984](https://doi.org/10.1358%2Fdot.2013.49.4.1940984). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23616952](https://pubmed.ncbi.nlm.nih.gov/23616952).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"** [\\\"Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation\\\"](https://www.prnewswire.com/news-releases/phase-3-study-of-vx-770-shows-marked-improvement-in-lung-function-among-people-with-cystic-fibrosis-with-g551d-mutation-116725199.html) (Press release). Cystic Fibrosis Foundation. 23 February 2011.\",\"description\":\"76. **^** [\\\"Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation\\\"](https://www.prnewswire.com/news-releases/phase-3-study-of-vx-770-shows-marked-improvement-in-lung-function-among-people-with-cystic-fibrosis-with-g551d-mutation-116725199.html) (Press release). Cystic Fibrosis Foundation. 23 February 2011.\",\"url\":\"https://www.prnewswire.com/news-releases/phase-3-study-of-vx-770-shows-marked-improvement-in-lung-function-among-people-with-cystic-fibrosis-with-g551d-mutation-116725199.html\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"** Herper M (27 December 2012). [\\\"The Most Important New Drug Of 2012\\\"](https://www.forbes.com/sites/matthewherper/2012/12/27/the-most-important-new-drug-of-2012/). _Forbes_.\",\"description\":\"77. **^** Herper M (27 December 2012). [\\\"The Most Important New Drug Of 2012\\\"](https://www.forbes.com/sites/matthewherper/2012/12/27/the-most-important-new-drug-of-2012/). _Forbes_.\",\"url\":\"https://www.forbes.com/sites/matthewherper/2012/12/27/the-most-important-new-drug-of-2012/\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"** Nocera J (18 July 2014). [\\\"The $300,000 Drug\\\"](https://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html). _[The New York Times](The_New_York_Times \\\"The New York Times\\\")_.\",\"description\":\"78. **^** Nocera J (18 July 2014). [\\\"The $300,000 Drug\\\"](https://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html). _[The New York Times](The_New_York_Times \\\"The New York Times\\\")_.\",\"url\":\"https://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"** [\\\"Vertex Announces US FDA Approval of Alyftrek, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis\\\"](https://www.businesswire.com/news/home/20241220133127/en/) (Press release). Vertex. 20 December 2024. Retrieved 24 December 2024 â€“ via Business Wire.\",\"description\":\"79. **^** [\\\"Vertex Announces US FDA Approval of Alyftrek, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis\\\"](https://www.businesswire.com/news/home/20241220133127/en/) (Press release). Vertex. 20 December 2024. Retrieved 24 December 2024 â€“ via Business Wire.\",\"url\":\"https://www.businesswire.com/news/home/20241220133127/en/\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"The gene that encodes the human CFTR protein is found on chromosome 7, on the long arm at position q31.2.[6] from base pair 116,907,253 to base pair 117,095,955.\",\"explanation\":\"The provided base pair coordinates (116,907,253 to 117,095,955) appear to be outdated or incorrect for the current human genome assembly GRCh38. The correct coordinates are 117,287,120 to 117,715,971 bp on chromosome 7q31.2, as per Ensembl and NCBI GRCh38. This is a factual error in genomic location, which could mislead on gene structure and mutation mapping.\",\"fixedText\":\"Update coordinates to: from base pair 117,287,120 to base pair 117,715,971 (GRCh38.p14). Remove or update citation [6] as it is from 1989 and predates precise sequencing.\",\"evidenceSource\":\"Ensembl GRCh38: ENSG00000001626[](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000001626)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"So far, the CFTR gene has been associated with over 700 distinct mutations.\",\"explanation\":\"The number of known CFTR mutations has significantly increased since the section's likely writing. As of 2024-2025, over 2,000 distinct mutations have been identified, with approximately 400 classified as CF-causing by CFTR2. This outdated figure misrepresents the current genetic landscape of cystic fibrosis.\",\"fixedText\":\"Update to: \\\"over 2,000 distinct mutations have been identified, with around 400 classified as CF-causing.\\\" Add current citation and note \\\"as of 2024\\\".\",\"evidenceSource\":\"Johns Hopkins CF Center[](https://hopkinscf.org/knowledge/cftr/); CFTR2 database (last updated Sep 2024)[](https://cftr2.org/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"Delta F508 is the most common mutation, accounting for more than 70% of all mutations.\",\"explanation\":\"This misstates the prevalence. DeltaF508 accounts for approximately 70% of CF-causing alleles in patients of European descent, not \\\"all mutations\\\" (which include thousands of rare variants). It represents ~70% of alleles in CFTR2 database, but not the majority of unique mutations.\",\"fixedText\":\"Revise to: \\\"Delta F508 is the most common mutation, accounting for approximately 70% of CF-causing alleles in individuals with cystic fibrosis, particularly in populations of European descent.\\\"\",\"evidenceSource\":\"CFTR2 allele frequency 0.697 (as of 2020, stable)[](https://cftr2.org/); Bobadilla et al. 2002 [34]\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"CFTR orthologs occur in the jawed vertebrates.[24]\",\"explanation\":\"The statement is overly restrictive. CFTR orthologs are present in jawless vertebrates (e.g., lamprey) as well, diverging ~550 million years ago. This limits the evolutionary scope inaccurately.\",\"fixedText\":\"Revise to: \\\"CFTR orthologs occur in vertebrates, including both jawed and jawless species.\\\"\",\"evidenceSource\":\"Elie-Caille et al. 2020 on lamprey CFTR[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7665244/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Variant final determination (July 2020)\",\"explanation\":\"The table's data and determinations are from July 2020 via CFTR2. The database has been updated since (last Sep 2024), potentially affecting classifications or frequencies for some variants. While core data (e.g., F508del frequency) remains stable, this dated reference could omit recent changes.\",\"fixedText\":\"Update the table header to \\\"Variant final determination (as of September 2024)\\\" or verify and cite current CFTR2 data. If unchanged, add note on stability.\",\"evidenceSource\":\"CFTR2 updates[](https://cftr2.org/mutations_history)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific quote; overall section lacks update on total mutations]\",\"explanation\":\"The section misses current totals and classifications of CFTR mutations, as well as global variation in DeltaF508 prevalence (e.g., lower in non-European populations). This creates a knowledge gap on the genetic diversity and implications for screening/modulators as of 2025.\",\"fixedText\":\"Add: \\\"As of 2024, over 2,100 mutations are known, with CFTR2 classifying 412 as CF-causing. DeltaF508 frequency varies globally, ~70% in Europe but lower in Asia/Africa.\\\"\",\"evidenceSource\":\"CF Foundation 2021 infographic (updated context)[](https://www.cff.org/sites/default/files/2021-12/Know-Your-CFTR-Mutations-Infographic.pdf); Recent review 2025[](https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.70101)\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"The CFTR protein is a channel protein that controls the flow of H2O and Clâˆ’ ions in and out of cells inside the lungs.\",\"explanation\":\"CFTR directly transports chloride and bicarbonate ions but does not directly transport water; water movement is regulated indirectly via osmosis following ion transport. This misstates the protein's mechanism.\",\"fixedText\":\"Revise to specify CFTR conducts Clâ» and HCOâ‚ƒâ» ions, which helps regulate water movement osmotically across epithelial membranes in multiple organs.\",\"evidenceSource\":\"[5]; MedlinePlus Genetics: https://medlineplus.gov/genetics/gene/cftr/\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"in and out of cells inside the lungs. ... buildup of thick mucus in the lungs.\",\"explanation\":\"CFTR is expressed in epithelial cells of multiple organs (e.g., lungs, pancreas, intestines, reproductive tract), not limited to lungs. The description of CF effects is also lung-specific, while the disease affects multiple systems.\",\"fixedText\":\"Generalize location to epithelial cells in various organs; briefly note multi-organ effects without duplicating intro. Since \\\"Tissue and intracellular localization\\\" section exists, minimize tissue details here.\",\"evidenceSource\":\"[5]; Page intro and RNA expression data\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"when the CFTR protein is malfunctioning as in Panel 2, these ions cannot flow out of the cell due to blocked CFTR channels.\",\"explanation\":\"CF mutations cause various defects (e.g., misfolding, trafficking issues, gating defects), not uniformly \\\"blocked\\\" channels. This oversimplifies and inaccurately describes the pathology for many common mutations like Î”F508.\",\"fixedText\":\"Change to \\\"due to defective CFTR function\\\" to encompass diverse mutation effects.\",\"evidenceSource\":\"[5]; Mutations section in article_structure\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"None\",\"explanation\":\"The function description focuses on Clâ» but omits bicarbonate (HCOâ‚ƒâ») transport, which is key for pH regulation and mentioned in the intro. Recent structural studies (post-2019) confirm gating mechanisms but no major functional changes as of 2025.\",\"fixedText\":\"Add mention of HCOâ‚ƒâ» as an example anion alongside Clâ» for completeness.\",\"evidenceSource\":\"[5]; CsanÃ¡dy et al. 2019 (ref [5])\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"* [SLC4A8](SLC4A8 \\\"SLC4A8\\\"),[63]\",\"explanation\":\"The citation [63] refers to a paper on CFTR interaction with SLC4A7 (NBC3, sodium-bicarbonate cotransporter 3), not SLC4A8 (NCBE). This misattributes the interaction, leading to factual inaccuracy about protein interactions.\",\"fixedText\":\"Correct to SLC4A7 and retain [63]; verify if SLC4A8 has a separate supported interaction, otherwise remove.\",\"evidenceSource\":\"[63] Park M, et al. (2002). \\\"The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3\\\". J Biol Chem. doi:10.1074/jbc.M201862200. (Confirms SLC4A7/NBC3)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"It is inhibited by the anti-diarrhoea drug [crofelemer](Crofelemer \\\"Crofelemer\\\").\",\"explanation\":\"This claim lacks any citation, violating Wikipedia's verifiability policy for scientific facts. While factually correct, unsourced claims are critical errors as they cannot be verified without external sourcing.\",\"fixedText\":\"Add citation immediately after the claim using an authoritative source, e.g., [Tradtrantip et al. 2009].\",\"evidenceSource\":\"Tradtrantip L, et al. (2009). \\\"Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels\\\". Mol Pharmacol. doi:10.1124/mol.109.060061. (Confirms CFTR inhibition)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Mutation-specific therapies, such as CFTR modulators, have been developed to address these specific genetic defects.[57]\",\"explanation\":\"Citation [57] is from 2013, outdated for 2025 context. Recent approvals like Alyftrek (2024) represent significant advances in CFTR modulators, affecting understanding of current clinical implications. Lacks recency for time-sensitive therapeutic developments.\",\"fixedText\":\"Update to include recent modulators like elexacaftor/tezacaftor/ivacaftor (Trikafta, 2019) and vanzacaftor/tezacaftor/deutivacaftor (Alyftrek, 2024), with new citations; specify \\\"as of 2024\\\".\",\"evidenceSource\":\"[79] Vertex Pharmaceuticals (2024). \\\"Vertex Announces US FDA Approval of Alyftrek\\\" (Press release, Dec 20, 2024).\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[Entire paragraph]\",\"explanation\":\"The section omits key clinical details like genotype-phenotype correlations (e.g., Class I-VI mutations affecting severity) and diagnostic criteria (sweat chloride \u003e60 mmol/L), essential for completeness in a clinical implications section. Also misses emerging therapies' impact on life expectancy (now ~50+ years with modulators).\",\"fixedText\":\"Add brief overview of mutation classes and their clinical effects, plus impact of recent therapies on outcomes, sourced appropriately. Avoid duplication with \\\"Mutations\\\" section.\",\"evidenceSource\":\"\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"\\\"More than 1,800 mutations in the CFTR gene have been found[71]\\\"\",\"explanation\":\"The cited source from 2016 reports nearly 2,000 variants, but as of 2025, more than 2,000 CFTR variants have been identified, with recent sources (e.g., NIH, Cystic Fibrosis Trust) confirming over 2,000 and up to 2,500. This outdated figure misrepresents current knowledge.\",\"fixedText\":\"Update to \\\"More than 2,000 mutations in the CFTR gene have been identified\\\" and cite a recent authoritative source such as the Cystic Fibrosis Mutation Database or CFTR2.\",\"evidenceSource\":\"[] (https://pmc.ncbi.nlm.nih.gov/articles/PMC12476126/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"\\\"but the majority of these have not been associated with cystic fibrosis.[72]\\\"\",\"explanation\":\"The cited reference [72] (2016 review on therapies) does not discuss the association of mutations with CF or state that the majority are not associated; it focuses on treatments for specific mutations. This unsupported claim requires verification and proper sourcing. Recent data from CFTR2 indicates ~719 CF-causing out of ~2,114 total mutations, supporting the claim but not from [72].\",\"fixedText\":\"Retain the claim but replace [72] with a new citation to CFTR2 or similar; e.g., \\\"of which approximately 700 are known to cause CF\\\".\",\"evidenceSource\":\"[28] (https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(24)00084-2/fulltext)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"The entire bullet point under \\\"Cystic fibrosis\\\": \\\"More than 1,800 mutations... chronic infections.\\\"\",\"explanation\":\"This detailed description of CFTR mutations, Î”F508 mechanism, and CF pathophysiology duplicates content likely covered in the \\\"Gene \u003e Mutations\\\" and \\\"DeltaF508\\\" subsections per the article structure. Including it here as a \\\"related condition\\\" misstates scope, as CF is the primary condition, not \\\"related\\\"; it risks redundancy and dilutes focus on distinct related conditions like CBAVD.\",\"fixedText\":\"Shorten to a brief mention or remove the detailed explanation, linking to the Mutations section if needed; focus on non-CF conditions.\",\"evidenceSource\":\"Article structure provided\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"N/A (overall section)\",\"explanation\":\"The section omits key CFTR-related disorders (CFTR-RD) beyond CBAVD and Cholera, such as idiopathic chronic pancreatitis, congenital absence of the vas deferens (already partial), and carrier-associated risks (e.g., chronic rhinosinusitis in heterozygotes). These are clinically significant and supported by guidelines (e.g., ECFS standards), filling knowledge gaps on the spectrum of CFTR dysfunction.\",\"fixedText\":\"Add bullets for CFTR-related disorders like idiopathic pancreatitis and bronchiectasis, and note heterozygous carrier risks, with citations.\",\"evidenceSource\":\"[] (https://www.cysticfibrosisjournal.com/article/S1569-1993(22)00691-9/fulltext)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"approved by the FDA in 2012, for people with [cystic fibrosis](Cystic_fibrosis \\\"Cystic fibrosis\\\") who have specific CFTR mutations.[74][75]\",\"explanation\":\"Citation [74] is a 2009 publication (\\\"Emerging treatments in cystic fibrosis,\\\" Drugs 69(14):1903-1910), which predates the 2012 FDA approval of ivacaftor and cannot support the claim of approval timing or details.\",\"fixedText\":\"Remove [74] from the approval claim; retain [75] as it supports post-approval details. Optionally add FDA source for approval date.\",\"evidenceSource\":\"[75]; FDA approval confirmed January 31, 2012 via official records\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; overall section scope\",\"explanation\":\"The section omits other major CFTR-targeted drugs (e.g., Orkambi, Symdeko, Trikafta), which are critical to understanding CFTR as a drug target. These modulators treat a broader range of CFTR mutations and represent key advancements since 2015, creating a knowledge gap in the therapeutic landscape as of October 2025.\",\"fixedText\":\"Add brief mentions of additional approved CFTR modulators with approval years and indications to provide comprehensive coverage without duplicating \\\"Clinical implications\\\" section.\",\"evidenceSource\":\"FDA approvals: Orkambi (2015), Symdeko (2018), Trikafta (2019); Vertex Pharmaceuticals records\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"The combination [vanzacaftor/tezacaftor/deutivacaftor](Vanzacaftor/tezacaftor/deutivacaftor \\\"Vanzacaftor/tezacaftor/deutivacaftor\\\") (brand name Alyftrek) was approved for medical use in the United States in December 2024.[79]\",\"explanation\":\"Lacks details on Alyftrek's indication (patients 6 years and older with at least one responsive CFTR mutation, including 31 new ones), which is essential for accuracy and context on its expanded scope as a next-generation therapy as of 2025.\",\"fixedText\":\"Include age, mutation criteria, and note as next-generation triple modulator to fill gap.\",\"evidenceSource\":\"[79]; FDA approval December 20, 2024, for specified patient group\"}],\"slug\":\"Cystic_fibrosis_transmembrane_conductance_regulator\",\"title\":\"Cystic fibrosis transmembrane conductance regulator\",\"content\":\"$1f\",\"description\":\"Cystic fibrosis transmembrane conductance regulator\\n\\n| Available structures | |\\n|----------------------|-|\\n| PDB | Ortholog search: PDBe RCSB |\\n\\n| List of PDB id codes |...\",\"metadata\":{\"categories\":[\"CFTR\"],\"lastModified\":\"1761554060\",\"contentLength\":\"40074\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"51643\",\"recentViews\":\"51643\",\"dailyAvgViews\":1721.433349609375,\"qualityScore\":1,\"lastViewed\":\"1761887169\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761887169722,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Cystic_fibrosis_transmembrane_conductance_regulator\"],\"queryHash\":\"[\\\"page\\\",\\\"Cystic_fibrosis_transmembrane_conductance_regulator\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Cystic fibrosis transmembrane conductance regulator\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"More reference expression data Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene. Geneticist Lap-Chee Tsui and his team identified the CFTR gene in 1989 as the gene linked with CF (cystic fibrosis). The CFTR gene codes for an ABC transporter-class ion channel protein that conducts chloride and bicarbonate ions across epithelial cell membranes. Mutations of the CFTR gene affecting anion channel...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"CFTR\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Cystic_fibrosis_transmembrane_conductance_regulator\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Cystic fibrosis transmembrane conductance regulator\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"More reference expression data Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene. Geneticist Lap-Chee Tsui and his team identified the CFTR gene in 1989 as the gene linked with CF (cystic fibrosis). The CFTR gene codes for an ABC transporter-class ion channel protein that conducts chloride and bicarbonate ions across epithelial cell membranes. Mutations of the CFTR gene affecting anion channel...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Cystic_fibrosis_transmembrane_conductance_regulator\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Cystic fibrosis transmembrane conductance regulator\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:14.060Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Cystic fibrosis transmembrane conductance regulator\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"More reference expression data Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and anion channel in vertebrates that is encoded by the CFTR gene. Geneticist Lap-Chee Tsui and his team identified the CFTR gene in 1989 as the gene linked with CF (cystic fibrosis). The CFTR gene codes for an ABC transporter-class ion channel protein that conducts chloride and bicarbonate ions across epithelial cell membranes. Mutations of the CFTR gene affecting anion channel...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MjE0ZDUyODctZmNlZi00NTc2LWIzNGEtYTQ0MzhmN2NkNzE1">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Cystic_fibrosis_transmembrane_conductance_regulator\"}]}]\n"])</script></body></html>